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Abstract 
The objective of this study was to investigate oxygen consumption (VO2) and heart rate 
(HR) response in competitive youth athletes without (ND) and with type 1 diabetes mellitus 
(T1D) during a simulated hockey game (SHG). There were no significant differences in the nadir, 
mean,  peak %VO2max and %HRmax values across the 3 periods of the SHG between T1D and 
ND (n=13) (p>0.05).  Significant differences (p<0.05) for the within T1D and ND group analysis 
are attributed to self-selected pacing during the play shifts and active recovery components of 
the SHG.  It is concluded that athletic adolescents with T1D achieve similar VO2max and HRmax 
values plus exhibit similar VO2 and HR responses during a SHG when compared to matched ND. 
Therefore adolescents with uncomplicated T1D can participate in sports; exercise and non-
exercise physical activity at the same level as their ND counterparts, and not be limited by 
diabetes. 
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CHAPTER 1 
LITERATURE REVIEW 
1.0  Type 1 Diabetes Mellitus 
Type I Diabetes Mellitus (T1D), formerly known as insulin-dependent diabetes or 
immune-mediated diabetes (Alberti & Zimmet, 1998; Weltman et al., 2009) has the highest 
incidence rates in youth under the age of 14 years in Canada (Canadian Diabetes Association, 
2012; DIAMOND Project Group, 2006). According to the Canadian Diabetes Association, T1D 
affects approximately 300,000 Canadians (or 10% of diagnosed diabetes). It is a metabolic 
disease that requires daily vigilant medical treatment and self-management to reduce the risk 
of future complications associated with chronic unstable dysglycemia (Weltman, Saliba, Barrett, 
& Weltman, 2009). The etiology of T1D is characterized by the autoimmune destruction of beta 
cells of the pancreas, where the rate of cell damage is variable between individuals (Alberti & 
Zimmet, 1998; Maahs, West, Lawrence, & Mayer-Davis, 2010; Shugart, Jackson, & Fields, 2010). 
The destruction of these cells prohibits the pancreas from secreting insulin, resulting in 
absolute insulin deficiency and forcing individuals to rely on the injection (or infusion) of 
exogenous insulin to stabilize blood glucose (BG) levels (Maahs et al., 2010; Shugart et al., 
2010). Exogenous insulin administration is critical for survival in persons with T1D, to prevent 
ketoacidosis, hypoglycemia, hyperglycemia and possibly death (Alberti & Zimmet, 1998). 
It is well known that the early onset of T1D, and its long-term physiological effects, 
increases the risk for the development of future disorders and diseases (Chu, Hamilton, 
&Riddell, 2011; Jones & Poole, 2005), such as cardiovascular disease (Veves et al., 1997). T1D is 
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associated with a greater than 3-fold increased risk of cardiovascular disease compared to 
individuals without T1D (ND) (Liese, Ma, Maahs, & Trilk, 2013). For this reason the importance 
of habitual physical activity (PA) participation is advocated, given the evidence confirming PA to 
be a behavioural factor that reduces the risk of cardiovascular disease, along with many other 
chronic diseases and conditions (Liese et al., 2013). The Diabetes Control and Complications 
Trial research group showed that keeping BG levels as close to the ND range as possible reduces 
the risk of developing major long-term complications associated with T1D, including 
retinopathy, neuropathy, and nephropathy (Diabetes Control and Complications Trial, 1995; 
Jacobsen, Henriksen, Hother-Nielsen, Vach, & Beck-Nielson, 2009; Nathan et al., 2005). It is 
therefore critical for individuals to manage and sustain a healthy BG range, which can be done 
by partaking in a vigilant treatment plus self-management routine (Landt, Campaigne, James, & 
Sperling, 1985; Sideraviciute, Gailiuniene, Visagurskiene, & Vizbaraite, 2006; Weltman et al., 
2009). By balancing insulin therapy and diet, most persons with T1D can manage their BG 
reasonably well (Canadian Diabetes Association, 2012). However, participation in non-exercise 
and exercise PA imposes additional and very unique challenges to the task of BG management 
(Canadian Diabetes Association, 2012). 
 
1.1  Type 1 Diabetes and Physical Activity 
PA plays a critical role in both the prevention and management of multiple chronic 
diseases and conditions, with T1D being one of them. Clinical guidelines for non-exercise and 
exercise PA participation for persons with T1D are still evolving (Chimen et al., 2012; Liese et al., 
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2013). A large proportion of the evidence-based PA guidelines for individuals with T1D are 
grounded on understandings gained from studies investigating the benefits of PA interventions 
on type 2 diabetes (T2D) (Chimen et al., 2012; Liese et al., 2013). Presently the amount of 
evidence regarding the benefits of acute and chronic PA participation in T2D exceeds the 
information that is available for T1D (Chimen et al., 2012). Nonetheless, the limited number of 
studies and comprehensive reviews focusing on the health benefits of PA participation in 
persons with T1D clearly demonstrate its advantages in this population. 
Regular non-exercise (ie. climbing the stairs, household chores) and exercise PA 
participation can confer the same health benefits in persons with and without T1D (Chu et al., 
2011; Guelfi, Jones, & Fournier, 2005). Specifically, in studies focused on T1D, PA has been 
proven to: improve blood pressure (Chu et al., 2011), glucose uptake (Norris, Carroll, & 
Cochrane, 1990), assist with weight management (Landt et al., 1985; Norris et al., 1990), 
enhance cardiovascular plus peripheral vascular function (Landt et al., 1985; Mosher, Nash, 
Perry, LaPerriere, & Goldberg, 1998), improve musculoskeletal fitness (Chu et al., 2011; Mosher 
et al., 1998), improve the blood lipid profile (Campaigne, Landt, & Mellies, 1985; Laaksonen et 
al., 2000), as well as, reduce stress, depression and the risks for developing cardiovascular plus 
peripheral vascular diseases (Chu et al., 2011; Guelfi et al., 2005; Komatsu, Castro, Saraiva, 
Chacra, & de Barros Neto, 2005; Sideraviciute et al., 2006; Veves et al., 1997; Zinker, 1999). 
Additionally, and with specific reference to young persons with T1D, participation in PA 
including competitive sports assists with social adaptation (Sideraviciute et al., 2006; Zinker, 
1999). It provides more opportunity for social interaction and allows them to integrate with 
their peers (Zinker, 1999). Therefore, regular non-exercise plus exercise PA is advocated and 
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should be a goal for youth with T1D, as it increases their sense of well-being, self-esteem, 
mitigates long-term complications and improves overall quality of life (Rowland, Martha Jr, 
Reiter, & Cunningham, 1992; Sideraviciute et al., 2006; Veves et al., 1997; Wasserman & 
Zinman, 1994; Zinker, 1999).  
Recent epidemiological data reveal that a significant number of youth with T1D do not 
participate in, or meet the current global PA guidelines set-out for youth; 60 minutes of 
moderate-to-vigorous PA per day (ParticipACTION, 2013; Liese et al., 2013). The 
epidemiological data show that a large proportion of these youth spend an excessive amount of 
time engaging in sedentary activities such as watching TV (Liese et al., 2013). Currently, there is 
very little data that describe the types of activities youth with T1D participate in, and, if they 
differ from those of their ND counterparts (Liese et al., 2013). The limited number of studies 
investigating youth with T1D reveal that their overall physical plus physiological fitness levels 
are in the low range (Liese et al., 2013), when compared to ND individuals matched for age and 
levels of PA (Chimen et al., 2012). 
 
1.2  Type 1 Diabetes and Metabolic Responses to Non-Exercise and Exercise Physical Activity 
Both non-exercise and exercise PA present a unique challenge for persons with T1D, as 
it further complicates daily BG regulation. The regulation of insulin release during PA in ND is 
met by a synchronized metabolic response (Gallen, 2005; Landt et al., 1985; Wasserman 
&Zinman, 1994; Zinker, 1999), where the increased energy demand and BG during exercise are 
matched by the release of insulin from the beta cells of the pancreas and increased glucose 
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utilization rate by the exercising muscles (Gallen, 2005; Landt et al., 1985; Zinker, 1999). For BG 
levels to remain constant during exercise, glucagon is released from the pancreas to increase 
hepatic glucose production (Chu et al., 2011). This homeostatic response is what persons with 
T1D lack, and it can be particularly problematic for the athlete with T1D (Gallen, 2005; Landt et 
al., 1985; Wasserman & Zinman, 1994; Zinker, 1999). The inability of athletes with T1D to 
automatically regulate insulin delivery increases the risk for severe hyperglycemia or 
hypoglycemia, both during and post exercise. It is critical for athletes with T1D to pay close 
attention to insulin administration before, during and after PA participation. With an 
inadequate amount of insulin, active persons with T1D will experience a decrease in insulin-
mediated glucose uptake by the muscles, along with the exercise induced release of glucose 
from the liver (Riddell & Perkins, 2006; Toni, Reali, Barni, Lenzi, & Festini, 2006; Tonoli et al., 
2012) which leads to rising BG levels during and post exercise resulting in hyperglycemia 
(Riddell & Perkins, 2006; Toni et al., 2006; Tonoli et al., 2012). Hyperglycemia will persist 
following exercise unless insulin is administered. If the exercise intensity is high, requiring 
vigorous-to-maximum effort (Figure 1), individuals may experience a further increase in 
hyperglycaemia and ketoacidosis, especially if the individual has poor glycemic control (Jain, 
McVie, & Bocchini, 2006; Riddell & Perkins, 2006; Toni et al., 2006; Tonoli et al., 2012). 
Ketoacidosis occurs from an increased production of ketones; when glucose can no longer be 
used as a fuel source due to insulin deficiency, body fuel is then derived from fat releasing 
ketones (Jain et al., 2006; Riddell &Perkins, 2006). Hyperglycaemia and ketoacidosis may result 
in dehydration and decreased blood pH, which will impair athletic performance and cause 
severe illness (Jain et al., 2006; Riddell &Perkins, 2006). A chronically sustained hyperglycaemic 
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state is a major risk factor for complications leading to blindness, neuropathy, and other 
vascular problems (Jain et al., 2006; Riddell & Perkins, 2006; Toni et al., 2006; Tonoli et al., 
2012).  
 
Figure 1: Physical activity intensity continuum corresponding with the recruitment order of the 
different muscle fiber types, health benefits and physical/physiological adaptations. 
Engaged Muscle Fibers: 
 Fast Twitch Glycolytic 
 Fast Twitch Oxidative Glycolytic   
Slow Twitch Oxidative 
Physical Activity Intensity Sedentary Light Moderate Vigorous Maximal 
Health Benefits None 
Minimum to Many 
Acute to Some Chronic 
Many 
Acute and Chronic 
Physical /Physiological  Fitness 
Adaptations 
None None to Some Enhanced 
Reprinted with permission from Jamnik and Gledhill (2015). Physical Activity and Lifestyle “R” Medicine: 
A Health-Related Physical Activity, Fitness and Lifestyle Rx. 
 
 
On the other hand, the opposite can occur, with excess circulating insulin; persons with 
T1D experience an accelerated rate of glucose uptake by the muscle, while glucose release from 
the liver is decreased (Riddell & Perkins, 2006; Toni et al., 2006; Tonoli et al., 2012). With 
hyperinsulinemia during exercise, glucagon release is inhibited resulting in a decrease in hepatic 
glucose production while glucose transport out of the blood continues (Chu et al. 2011). This 
imbalance between glucose uptake and production lowers BG levels leading to hypoglycemia, 
which is a priority during and after exercise as it can cause acute life-threatening complications 
(Riddell & Perkins, 2006; Toni et al., 2006; Tonoli et al., 2012). Therefore, athletes with T1D 
must be extremely vigilant in monitoring BG levels in order to prevent the complications that 
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occur from poor BG control. Despite the risks that non-exercise and exercise PA pose on this 
population and the lack of understanding regarding the possible limitations on exercise 
tolerance induced by unstable BG control, the literature still supports habitual non-exercise and 
exercise PA participation (Gallen, 2005; Komatsu et al., 2005; Veves et al., 1997).  
For many parents of children with T1D, there is a large concern around the topic of low 
blood glucose (i.e. hypoglycaemia) and particularly the strong link between hypoglycaemia and 
PA (Barnard, Thomas, Royle, Noyes, & Waugh, 2010; Frier, 2008; Robertson, Adolfsson, 
Scheiner, Hanas, & Riddell, 2009). Persons with T1D and their families are aware of the adverse 
effects of hypoglycemia and recognize that these episodes are potentially life threatening, as 
well as a source of social embarrassment (Barnard et al, 2010). As a result, parents and their 
children who have T1D may develop fear and anxiety towards the occurrence of hypoglycemic 
episodes and attempt to take measures to avoid hypoglycemia (Barnard et al., 2010). Di Battista 
et al. (2009) showed that social anxiety towards hypoglycemia is common in adolescents with 
T1D (mean age 15.9 ± 1.44 years), which interferes with their behaviour and quality of life. Fear 
of hypoglycemia is an important and highly prevalent barrier to the involvement in non-exercise 
and exercise PA in youth with T1D (Liese et al., 2013). While awareness can reduce the levels of 
fear, it is important to further investigate the physiological responses of young persons with 
T1D to both non-exercise and exercise PA.  The outcomes of this focussed research will provide 
diabetes professionals, parents and persons with T1D with the information that is essential for 
safe and effective PA participation (Robertson et al., 2009; Wild et al., 2007). 
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1.3  Oxygen Uptake during Rest and Physical Activity 
Skeletal muscles are responsible for facilitating movement and the capacity to carry out 
physical work (Jones & Poole, 2005). As such, the human body possesses a remarkable ability to 
alter its metabolic requirements in response to various energetic challenges, predominantly via 
oxidative metabolism (Poole, Kindig, Behnke, & Jones, 2004). Humans are rarely in situations of 
metabolic steady-state, rather, they engage in activities involving sudden transitions from one 
metabolic rate to another (Jones &Poole, 2005). The study of oxygen uptake (VO2) and VO2 
kinetics encompasses the physiological mechanisms responsible for the transition between 
metabolic rates during non-exercise and exercise PA (Poole et al., 2004). The rate of change 
during transitions between energy demands is a fundamental parameter of metabolic capacity, 
ultimately impacting exercise performance and tolerance (Poole et al., 2004). Aerobic or 
cardiorespiratory fitness, defined here as the ability and the efficiency of the body to extract 
oxygen from the atmosphere, transport it to the working muscles, and utilize the oxygen at the 
muscular and cellular level during prolonged moderate-to-high-to-maximum intensity exercise, 
is influenced by many factors including chronic disease, and therefore has been extensively 
examined and described by many. It is well known that by measuring the rate of VO2 during 
exercise, cardiorespiratory fitness can be evaluated (Gist, Fedewa, Dishman, & Cureton, 2014; 
Jones & Poole, 2005). Maximum oxygen uptake (VO2max or VO2peak) is considered to be the 
best net index of how efficiently the heart, lungs and muscles (Astrand, 1971; Komatsu et al., 
2005; Veves et al., 1997) function together when subjected to varying energy demands. 
Physiologically, VO2max represents the maximal rate at which the body can re-synthesize ATP 
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oxidatively (aka aerobically), providing an upper limit for endurance performance in athletes, 
sedentary, and patient populations (Jones & Poole, 2005). 
In the literature, the term VO2peak is also frequently used. This term may be defined as 
the highest VO2 value achieved during an aerobic or cardiovascular fitness test. It is different 
from VO2max and it is therefore important to highlight its distinction. Although VO2peak 
describes the highest VO2 value achieved during a cardiovascular fitness test, it does not 
necessarily define the maximum VO2 value attainable by an individual (Whipp, n.d.). Achieving a 
true VO2max depends on the determination of a particular criterion, where VO2 no longer 
increases, or only increases by a trivial amount, despite a further increase in work rate (Whipp, 
n.d.). VO2max tests involve high-intensity exercise and are designed to bring individuals to the 
limit of tolerance (Whipp, n.d.). An individual may not be able to achieve a true VO2max as a 
result of the inability to perform high-intensity exercise. As a result, the VO2peak is used as the 
measure of cardiovascular fitness instead of VO2max. 
 
1.4  Oxygen Uptake and Type 1 Diabetes 
The limitations associated with the pathology of T1D on exercise performance and/or 
tolerance are still not well understood. The majority of research regarding T1D and exercise 
centres around the glucoregulatory responses (Guelfi, Ratnam, Smythe, Jones, & Fournier, 
2007; Herbst, Bachran, Kapellen, & Holl, 2006; Metcaf et al., 2014; Zinman, Zuniga-Guajardo, & 
Kelly, 1984), whereas cardio respiratory or aerobic fitness has been inconsistently reported 
(Komatsu et al., 2005).  As summarized in Table 1, studies evaluating aerobic fitness in children, 
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non-athletic and athletic youth with T1D have demonstrated lower measured VO2max values 
when compared to their healthy counterparts (Austin, Warty, Janosky, & Arslanian, 1993; 
Komatsu et al., 2005; Nadeau et al., 2010). In the studies conducted by Arslanian, Nixon, 
Becker, & Drash (1990), Austin, et al. (1993), Faulkner (2010), and Faulkner, Quinn, Rimmer, & 
Rich (2005), VO2peak and VO2max were used as measures of aerobic fitness in youth with T1D. 
All four studies consistently reported VO2max and or VO2peak measures between 34-41 mL∙kg
-
1∙min-1, which for youth is classified as having low cardiorespiratory fitness (Liese et al, 2013). 
 
Table 1. Summary of the studies investigating aerobic fitness measured via VO2max values in 
children, non-athletic and athletic youth with and without T1D 
Author Age Sex VO2max (mL∙kg
-1∙min-1) 
Austin et al. 
(1993) 
15.6 ± 2.5 years M/F T1D- 33.7 ± 7.0 
ND- 41.0 ± 10.4 
Komatsu et al. 
(2005) 
9-20 years M/F T1D- 41.57 ± 7.68 
ND- 51.12 ± 9.94 
Nadeau et al. 
(2010) 
12-19 years M/F T1D- 31.5 ± 7.6 
ND- 40.4 ± 9.9 
 
 
In ND, there is a characteristic positive response in VO2 during incremental-to-maximum 
exercise (Regensteiner, Reusch, Stewart, & Veves, 2009). An increase in workload during 
exercise requires an increase in VO2 to meet the given energy demands, and this response 
describes the ability of the body’s physiological mechanisms to adjust to exercise demands 
(Regensteiner et al., 2009). A reduction in the slope of this positive relationship could reveal 
abnormalities in the physiological mechanisms behind the response, including a decrease in 
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oxygen delivery, cardiac function, and/or an irregularity of muscle oxidative metabolism 
(Regensteiner et al., 2009). In cardiorespiratory and vascular disease, it has been demonstrated 
that a decrease in the slope of VO2 indicates abnormalities or insufficiencies in cardiac output 
and gas exchange (Regensteiner et al., 2009). Specific to T1D, Austin et al. (1993) and Komatsu 
et al. (2005) reported that physiological fitness, as measured by VO2peak, is associated with 
glycemic control, where Austin et al. (1993) concluded that a lower fitness predicted higher 
glycated hemoglobin (HbA1c) levels. It is still unclear in the literature how VO2max (or VO2peak) 
and HbA1c levels are related; whether a lower measured aerobic fitness elevates HbA1c levels, 
or higher HbA1c levels contributes to a lower fitness. Other studies investigating the 
mechanisms behind the impaired functional aerobic fitness observed in this population have 
linked it to idiopathic structural and functional changes within the cardiac and skeletal muscle 
(Hilsted, Galbo, & Christensen, 1979; Jones & Poole, 2005; Mildenberger et al., 1984; Nadeau et 
al., 2010; Vered et al., 1984; Veves et al., 1997; Williams et al., 2011). It is possible that along 
with the lower VO2max or VO2peak observed in individuals with T1D, the rate of VO2 during 
exercise could also be impaired. 
 
1.5  Oxygen Uptake Kinetics 
How well an individual physiologically copes with the demands of exercise depends, in 
part, upon the rate of oxygen uptake, or VO2 kinetics (Jones & Poole, 2005). The rapid increase 
in VO2 at the onset of and during incremental exercise (deemed as O2 kinetics) requires the 
coordination between the respiratory, cardiovascular, and muscular systems to transport 
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oxygen from the atmosphere, plus circulate, deliver, and utilize it at the cellular level (Jones & 
Poole, 2005; Whipp, 1994; Wasserman & Whipp 1972). The difference in the rate of VO2 
kinetics delineates ranges in athletic performance, where trained individuals have faster VO2 
kinetics compared to healthy untrained individuals, who sequentially have faster VO2 kinetics 
than persons with chronic diseases or conditions (Jones & Poole, 2005). 
1.5.1  A Brief History of Oxygen Uptake Kinetics 
The pioneers of the study of VO2 kinetics have made major contributions within the field 
and are inherently responsible for setting the foundation of VO2 kinetics (Jones & Poole, 2005). 
Since Krogh and Lindhard (1913) first reported on the fast cardiovascular responses seen at the 
onset of exercise, the dynamics of the VO2 response has been described and studied extensively 
(Xu & Rhodes, 1999). In the 1920s, Hill and colleagues were the first to demonstrate the 
exponential nature of the VO2 response at the beginning of exercise in humans (Hill, Long, & 
Lupton, 1924; Jones & Poole, 2005). The energy and supply demand model proposed by Hill et 
al. (1924) suggested that running performance was determined by three factors: energy 
demand (VO2 required), VO2 max, and sustained aerobic capacity; and is the foundation on 
which recent models are built (Jones & Poole, 2005). Later on, Whipp and Wasserman had the 
advantage of newer technology (breath-by-breath measurements of ventilation and pulmonary 
gas exchange) to establish the 3-phase VO2 response at the beginning of exercise, validate the 
physiological mechanisms responsible, and describe the relationship between VO2 kinetics and 
exercise intensity (Jones & Poole, 2005). Lamarra and Wasserman developed the equations 
used to measure breath-by-breath alveolar gas exchange that are still used today (Jones & 
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Poole, 2005). With the advances in technology and the manufacture of reliable gas analysis 
systems for the measurement of VO2, it is now possible to plot and model the kinetics of the 
VO2 response. 
 
1.5.2  Traditional Method of Measuring Oxygen Uptake Kinetics 
During steady-state exercise, VO2 increases linearly as a function of work rate (Whipp, 
1994; Xu & Rhodes, 1999). This response during the transition from rest to steady-state 
exercise has been described by Whipp, Ward, Lamara, Davies, and Wasserman (1982) to 
include three phases (Barstow & Mole, 1991). The initial phase is defined as the early rapid 
response or “cardiodynamic stage”, the second phase is characterized by the slower 
exponential increase of the response and described as the “fundamental stage,” and the third 
phase refers to the “slow component” representing steady-state (Barstow & Mole, 1991; Carter 
et al., 2000; Jones & Poole, 2005; Whipp, 1994). All three of the phases are associated with to 
specific physiological mechanisms reflecting the initial increase of pulmonary VO2 in the lungs, 
the increase of muscle VO2 via mean tissue gas exchange, and the utilization of oxygen at the 
muscle level for the metabolic requirements of the body during steady-state exercise (Whipp, 
et al., 1982; Wasserman & Whipp, 1972). The three components of the kinetic behavior of VO2 
can be described by applying an exponential model: 
ΔVO2(t) = VO2(b) + A(1 – e
-t/T) 
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Where ΔVO2(t) is the increase in VO2 at time (t); VO2(b) is the baseline VO2; A is the response 
(steady-state) amplitude; 1 – e is the base for the natural logarithm; and T is the time constant 
(Carter, Pringle, Barstow, & Doust, 2006; Jones & Poole, 2005; Whipp, 1994). This first-order 
exponential model calculates the rate of change (or slope of the line) of VO2 at a specified time, 
reflecting the efficiency of the physiological mechanisms that drive VO2, such as the adequate 
functioning of the O2 transport chain (Jones & Poole, 2005; Whipp, 1994). 
At the start of moderate-intensity exercise which is 40-60% of VO2max or 55-69% of 
maximal heart rate (HRmax) (Guelfi, Jones, & Fournier, 2007), VO2 initially increases rapidly and 
then steady-state is achieved within 1.5-3 minutes (Zoladz et al., 2013). The time constant 
(defined as the characteristic transition time representing the speed at which a particular 
system can respond to change) of the VO2 increase observed at the start of exercise varies 
between individuals (Grassi, Porcelli, Salvadego, & Zoladz, 2011; Zoladz et al., 2013). The faster 
the VO2 kinetics, the greater the exercise tolerance and fitness level of the individual; therefore 
endurance trained athletes have a significantly shorter time constant 10-20 seconds, and 
deconditioned persons plus persons with chronic diseases or conditions have a substantially 
longer time constant (40-60 seconds) (Jones & Poole, 2005; Zoladz et al., 2013). Endurance 
trained athletes will have a smaller O2 deficit (Figure 2), accompanied by less disturbance in 
muscle metabolic stability (ie. lower acid-based disturbance) (Grassi et al., 2011; Jones & Poole, 
2005; Zoladz et al., 2013). Unfit or unhealthy individuals will have a very slow response with 
time constants between 20-45 seconds and 40-60 seconds, respectively (Jones & Poole, 2005; 
Zoladz et al., 2013). As a result, these individuals will experience a larger O2 deficit (Jones & 
Poole, 2005; Poole, Barstow, McDonough, & Jones, 2008; Zoladz et al., 2013) and mandate a 
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greater degree of intramuscular disturbance (decreased pH, ADPfree, and inorganic phosphate, 
as well as greater depletion of phosphocreatine) (Jones & Poole, 2005; Poole et al., 2008). 
These factors predispose individuals to reduced exercise performance and tolerance (Jones & 
Poole, 2005; Zoladz et al., 2013). Thus pathological conditions, such as T1D, may alter the 
efficiency of the VO2 kinetic response. Given that glycemic control and changes in cardiac 
muscle function affect VO2max, these factors may also affect the VO2 kinetics in T1D, incurring 
a significantly slowed VO2 response to exercise. It is essential to characterize the behaviour of 
the VO2 response to PA in persons with T1D to facilitate the investigation of the underlying 
causes of exercise intolerance, and to develop therapeutic strategies to improve physical plus 
physiological fitness and quality of life (Poole et al., 2008).  
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Figure 2. VO2 during the transition from rest to steady-state exercise 
 
A  B   
 
(Powers & Howley, 2011) 
 
Panel A. The shaded area illustrates the O2 deficit, representing the lag in VO2 at the start of 
exercise. Panel B. Comparing the differences in the time course of VO2 from rest to steady-state 
exercise between trained and untrained individuals. In untrained individuals, the time to reach 
steady-state VO2 is slower compared with trained individuals; as a result, untrained individuals 
have a greater O2 deficit. 
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1.6  Oxygen Uptake Kinetics and Type 1 Diabetes 
In the healthy population, limitations in highan individual’s VO2 kinetics during exercise 
could be a result of either inadequate blood flow to working tissues limiting oxygen transfer, or 
the inertia of oxidative metabolism (Regensteiner et al., 2009). In diseased states like 
cardiovascular disease or perhaps diabetes, oxygen delivery is compromised and the VO2 
kinetics are restricted by oxygen delivery to working muscles (Regensteiner et al., 2009). 
Currently, there are limited (or no) studies conducted on the VO2 kinetics during exercise in 
T1D, specifically in youth with T1D. However, there have been a handful of studies that have 
investigated the VO2 kinetics in premenopausal women with T2D (Ananey et al., 2011; Bauer, 
Reush, Levi, & Regensteiner, 2007; Brandenburg et al., 1999, Regensteiner et al., 1998). These 
studies reported that VO2peak or VO2max are consistently reduced in premenopausal women 
with T2D, and that the VO2 kinetics in this population adjust more slowly compared with 
healthy controls matched for age, body mass, and activity levels during the onset of 
submaximal cycling exercise (Ananey et al., 2011; Bauer et al., 2007; Brandenburg et al., 1999, 
Regensteiner et al., 1998). Although the participants were matched for activity level, the 
authors of the aforementioned investigations may not have matched for intensity or physical 
plus physiological fitness levels. The participants may have performed the same activities, but it 
is possible that the women with T2D and the ND worked at different intensities. The ND could 
have been working at higher intensities, which could account for the discrepancies found in 
VO2max and VO2peak between the investigations. 
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Similar to T1D, the cause of exercise intolerance in T2D is still not well understood 
(Regensteiner et al., 1998). Regensteiner et al. (1998) assessed the dynamics of VO2 kinetics in 
response to constant-load exercise in premenopausal women with T2D, and found there was a 
reduction in the cardiopulmonary response at the beginning of exercise. Regensteiner et al. 
(1998) noted that along with a possible compromised cardiac response to exercise in the 
participants with T2D, their VO2 kinetics could additionally be affected by inadequate skeletal 
muscle oxygen diffusion, mitochondrial density, or mitochondrial oxygen utilization. Ananey et 
al. (2011) investigated whether cardiac output responses to constant-load cycling at light versus 
moderate versus vigorous intensities were related to the VO2 kinetics during cycling exercise in 
women with uncomplicated T2D. The investigators observed that there was no cardiac 
dysfunction within the cohort with T2D and suggested that the slowed VO2 kinetic response is 
partly attributed to uneven distribution and slowed dynamic adaptations of blood flow to the 
exercising muscles (Ananey et al., 2011). Ananey et al. (2011) also noted that the reduced VO2 
kinetics of the participants with T2D during submaximal exercise might suggest a greater 
reliance on the anaerobic system causing increased fatigue and contributing to exercise 
intolerance. It is possible, although not highlighted in the manuscript, that the slower VO2 
kinetics observed in the cohort with T2D is a function of the lower baseline fitness levels. As 
previously discussed, individuals with T1D have been shown to have a lower VO2max or 
VO2peak and exercise tolerance than ND matched for age, body mass and PA level, and similar 
to T2D, this reduced cardiorespiratory fitness may not just be attributed to deconditioning. It is 
also important to note that while the PA levels may be the same between individuals with and 
without T2D, the intensities of the exercise may differ, which could account for differences in 
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VO2max. Drawing from the evidence gained from the T2D exercise research, one could presume 
that a lower VO2max or peak in T1D could also be attributed to a reduction in the dynamics of 
VO2 kinetics. 
 
1.7  Oxygen Uptake Kinetics and Exercise 
Traditionally, research focussed on the dynamic behaviour of VO2 use submaximal effort 
constant-load incremental exercise for their investigations. In numerous studies of VO2 kinetics, 
constant-load exercise was performed at moderate-to-vigorous intensity workloads below the 
lactate threshold. This approach was employed because it controls the rate of progression in 
workloads and assures a steady-state VO2 (Regensteiner et al., 1998). Wasserman & Whipp 
(1972) investigated the effect of various work intensities on the VO2 kinetics in 6 healthy 
volunteer using an exercise protocol that involved participants cycling at a constant-load for 6 
minutes at a given workload to achieve a steady-state VO2. Brandenburg et al. (1999) and 
Regensteiner et al (1998) also used constant-load exercise on cycle ergometers in their studies 
of VO2 kinetics in premenopausal women with T2D. It is important to note that not all PA 
encountered throughout the day is at a steady-state. Many activities incorporate brief, 
intermittent bouts of high intensity activity interspersed with rest periods, similar to the short 
sprints inherent in multiple team and field sports and spontaneous play of children (Bigger, 
Fleiss, Rolnitzky, & Steinman, 1993; Robertson et al., 2009). It is imperative to understand the 
physiological response of active youth with T1D to multiple forms of non-exercise and exercise 
PA to ensure safe participation and optimize sport performance.  
20 
 
1.8  High-Intensity Intermittent Exercise 
Many sports, like hockey in particular, are defined by short, high-intensity intermittent 
bouts of activity (Montgomery, 1988). High-intensity intermittent training (HITT) is 
characterized by brief bouts of vigorous-to-maximum effort. These short periods of high-
intensity activity cannot be maintained for very long, and therefore are separated by intervals 
of light intensity PA (Burgomaster, Heigenhauser, & Gibala, 2006; Gibala et al., 2009). High-
intensity exercise occurs at 80-100% of VO2max or greater than 75% of HRmax (Guelfi et al., 
2007). 
HITT has been proven in the literature to be an effective strategy for inducing skeletal 
muscle oxidative and metabolic adaptations similar to the changes seen with chronic moderate-
to-vigorous intensity endurance training (Burgomaster et al., 2006; Burgomaster et al., 2008; 
Gibala et al., 2009; Harmer et al., 2008). This has been the focus of the majority of research in 
this area. Gibala et al. (2006) reported that sprint interval training (SIT) involving 4-6 bouts of 30 
second “all out” cycling at approximately 250% of the workload that elicited the VO2peak, 
induced improvements in muscle oxidative capacity (reflected by the maximum activity of 
cytochrome C oxidase and COX subunit protein content), muscle buffering capacity and exercise 
performance (measured by total cycling time and mean power output) to the same extent as 
did traditional continuous moderate-to-vigorous intensity training involving 90-120 minutes of 
continuous cycling at approximately 65% of VO2peak. In another study, Burgomaster et al. 
(2008) showed that a low volume of SIT involving 4-6 30 second “all out” Wingate tests, elicited 
similar adaptations in specific mitochondrial markers for skeletal muscle carbohydrate and lipid 
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metabolism and metabolic control (reduced glycogen and phosphocreatine utilization) 
compared with traditional continuous moderate-to-vigorous intensity endurance training 
involving 40-60 minutes of continuous cycling at approximately 65% VO2peak. Along with the 
myocellular adaptations, HITT and SIT are also associated with increases in VO2max or peak and 
work tolerance (Burgomaster et al., 2008; Burgomaster, Hughes, Heigenhauser, Bradwell, & 
Gibala, 2005; Gibala et al., 2006). In the aforementioned studies (Gibala et al., 2006 and 
Burgomaster et al., 2008) the researchers included participants who had no health 
complications and were recreationally active or untrained, respectively. One study in particular 
investigated the muscle oxidative adaptations to HITT in young adults with T1D (Harmer et al., 
2008). The findings demonstrate that during intense exercise, HITT increased muscle oxidative 
capacity and reduced muscular metabolic destabilization (reducing lactate accumulation, 
glycogenolytic and glycolytic rates, and attenuated ATP degradation) in T1D. The participants 
did not experience any adverse effects due to HITT and Harmer et al. (2008) concluded that 
HITT is well tolerated by persons with T1D. 
 
1.9  High-Intensity Intermittent Exercise and Type 1 Diabetes 
Recently, the glucoregulatory response to HITT in T1D has been investigated and this 
type of exercise has been associated with higher BG concentrations. Studies reported that brief 
high-intensity bouts could attenuate the typical drop in BG concentration, both during and after 
moderate intensity exercise in T1D (Guelfi et al., 2005; Bussau, Ferreira, Jones, & Fournier, 
2006; Bussau, Ferreira, Jones, & Fournier, 2007; Robertson et al., 2009). Bussau et al. (2006) 
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investigated the repercussions of a 10-second maximal cycling sprint following 20 minutes of 
moderate-intensity cycling exercise in males with T1D aged 21 ± 3.5 years. When the 
investigators introduced a 10-second cycling sprint at the end of the 20-minute workout, the 
decline in BG was no longer apparent for 2 hours following cessation of the activity. The 
investigators discovered that adding a short maximal sprint counters the rapid fall in glucose 
associated with continuous moderate-intensity exercise, and thus, provides another means to 
attenuate or offset the risk of hypoglycemia in active persons with T1D independent of pre-
exercise dietary or insulin adjustments. Bussau et al. (2006) proposed that the mechanisms 
responsible for attenuating the exercise-mediated decrease in BG concentration and the 
stabilization of BG after exercise is consequence of the elevated levels of counterregulatory 
hormones including catecholamines, growth hormone, plus cortisol and lactate levels. When 
persons with T1D participate in intermittent high-intensity exercise, BG levels fall less rapidly 
and remain more stable following the activity in comparison to sustained light-to-moderate-
intensity exercise (American Diabetes Association, 2004). 
Most team and individual sports have a HITT component. Guelfi et al. (2007) 
demonstrated the glucoregulatory behavior in response to a bike protocol simulating activity 
patterns of team sports. The protocol involved, 30 minutes of continuous exercise at 40% of 
VO2peak, interspersed with 4 maximal sprint efforts every 2 minutes. Currently, this is one of 
the only studies that investigated a HITT protocol tailored to simulate a game situation in T1D. 
More research is required on this type of activity for persons with T1D, as it will assist in 
creating detailed, evidenced-based guidelines for safe participation in regular intermittent high-
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intensity exercise and sports. To date, no study has evaluated the cardiorespiratory responses 
to such exercise in individuals with T1D. 
 
1.10  Heart Rate Kinetics 
The heart rate (HR) response during PA is closely related to the rate of change of VO2 
and like VO2 kinetics, HR may also be described mathematically as an exponential function 
(Stirling, Zakynthinaki, Refoyo, &Sampedro, 2008). Measuring the HR kinetics during exercise is 
frequently used as a simple way of assessing the degree of adaptation to a submaximal effort 
exercise bout and evaluating the functional circulatory capacity (Bunc, Heller, & Leso, 1988). 
During constant-load submaximal effort exercise the kinetics of the HR response can be 
separated into distinct physiological phases, similar to what has been observed with the VO2 
kinetics (Bunc, Heller, Leso, &Sprynarova, 1986). The initial phase of the HR response during 
exercise is designated as the “fast” component, while the second is deemed the “slow” 
component (Bunc et al., 1986). In a study by Bunc et al. (1988), the investigators used a mono-
exponential model to determine the behaviour in HR at the onset of constant-load sub-maximal 
effort exercise on a cycle ergometer. The investigators confirmed, using healthy endurance 
trained and untrained males, that the kinetics of HR can be characterized by applying the same 
type of model used to describe VO2 kinetics (i.e. a fast and slow component) and concluded 
that the change in HR during submaximal steady-state exercise can help assess the functional 
capacity and training state of individuals (Bunc et al., 1988). Since the basic response patterns 
for VO2 and HR kinetics are similar in response to incremental steady-state submaximal exercise 
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(Stirling et al. 2008), Ananey et al. (2011), and Regensteiner et al. (1998) adapted the 
mathematical models developed for VO2 kinetics to apply to HR in their T2D studies. 
Comparable to VO2 kinetics, the HR dynamics at the start of exercise are faster with a 
more advanced state of training, and thus trained individuals have faster HR kinetics in 
comparison to untrained individuals (Bunc et al., 1988). Like VO2 kinetics, there is also a lack of 
research analysing the HR kinetics in persons with T1D or T2D. Currently two studies have 
measured HR kinetics in T2D, and found conflicting results (Ananey et al., 2011; Regensteiner et 
al., 1998). Along with VO2 kinetics, Regensteiner et al. (1998) examined the HR kinetics of 
premenopausal women with uncomplicated T2D and found that compared to the ND, the T2D 
had slower HR kinetics during constant-load cycling exercise. Regensteiner et al. (1998) 
attributed a possible impaired cardiac response to the slower HR kinetics observed in the 
women with T2D. In contrast, Ananey et al. (2011) found no differences in the HR kinetics 
between middle-aged women with uncomplicated T2D and ND at any time point during the 
constant-load cycling exercise. Thus, more research is needed to confirm if HR kinetics during 
exercise are impaired in diabetes, and if a reduction in HR kinetics influences the VO2 kinetic 
response. Investigating both VO2 and HR kinetics in active youth with T1D will provide a more 
profound understanding of the limitations to exercise performance and tolerance induced by 
diabetes. 
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1.11  Type 1 Diabetes and Hockey 
The sport of ice hockey is both physically demanding and multifactorial (Burr et al., 
2008), as it involves full body contact, moderate-to-vigorous and vigorous-to-maximum or  
high-intensity intermittent skating with frequent changes in velocity and duration 
(Montgomery, 1988). Research is needed for hockey athletes because of its high-intensity 
intermittent nature, which demands its athletes to possesses high levels of muscular strength, 
power, endurance, aerobic power, anaerobic power and anaerobic-aerobic power 
(Montgomery, 1988). A typical hockey player will spend 15-20 minutes of a 60-minute game on-
ice, performing at high-intensities in shifts that last 30-80 seconds interspersed with 4-5 minute 
passive rest periods in between (Montgomery, 1988). During on-ice hockey shifts, peak HR 
exceeds 90% of HRmax, with average on-ice values of approximately 85% or more of HRmax 
(Montgomery, 1988). Top performance in this sport necessitates an efficient aerobic system to 
be able to recover quickly between shifts and to meet the energy demands throughout the 
duration of a game (Montgomery, 1988).  
Traditionally the VO2max of hockey players is tested using continuous, incremental to 
maximum protocols (Montgomery, 2006). No studies have reported on the VO2 and HR kinetics 
during sport-specific exercise in T1D, leaving a large gap in this specific area. Studies need to be 
conducted that examine sport-specific intermittent exercise to characterize the behaviour of 
the aerobic (cardiovascular) system in response to this type of activity, where changes in effort 
and metabolic requirements frequently fluctuate, to provide insight into two basic questions: A) 
How the aerobic system of athletes with T1D responds across a full game has yet to be 
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characterized; and B) Are their cumulative VO2 and HR kinetics delayed in comparison to their 
healthy counterparts, and does this in turn impair or hinder their performance in the sport? It is 
important to indicate the differences between T1D and their healthy counterparts in order to 
understand their limitations and help these athletes achieve their full athletic potential.  
Due to the lack of research examining HITT in persons with diabetes, research-based guidelines 
specific to hockey players with T1D do not exist. This creates yet another challenge for young 
athletes with T1D and their families in terms of insulin therapy and BG management. It forces 
them to discover their own strategies for BG management through trial and error or by 
modifying the recommendations provided from other continuous moderate-to-vigorous 
intensity sports. This may have severe consequences for the athlete with T1D if proper 
precautions are not taken, and the possibility of life threatening situations could prematurely 
end their participation in ice-hockey due to uncertainty and fear. Future research is required to 
further understand how hockey players with T1D respond throughout an entire game. This 
knowledge will assist in the development of detailed, evidence-based guidelines enabling 
athletes with T1D to safely enjoy the benefits of regular non-exercise and exercise PA and to 
assist with the training of these athletes to achieve their full athletic potential and 
performance. 
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2.0  PURPOSE AND OBJECTIVE 
The purpose of the present study was to investigate the effects of a laboratory 
simulated hockey game on the VO2 and HR response in young, competitive athletes with T1D. 
While the principle objective is to determine whether the VO2 and HR response differs between 
T1D and healthy controls, it will be interesting to observe any general trends that may occur 
across the three periods of the games.   
Hypothesis 
We hypothesized that the game VO2 and game HR response, and %VO2max and 
%HRmax will be lower in the young hockey players with T1D compared to their healthy 
counterparts. 
 
2.1  METHODS 
Experimental data were collected in conjunction with another study conducted by 
Miadovnik (2013). All protocols were reviewed and approved by the Human Participants 
Review Sub-Committee at York University’s Office of Research Ethics. Throughout the study 
there were no adverse events to report on. 
 
 
 
29 
 
2.1.1  Study Participants and Recruitment 
Study participants were recruited through word of mouth techniques in the Greater 
Toronto Area. Recruitment targeted rep-level hockey players between the ages of 13-21 years, 
who were diagnosed with T1D at least 1 year prior. Recruitment flyers were distributed to 
endocrinologist and diabetes clinics, posted in various arenas and hockey-centered fitness 
facilities throughout the Toronto area, and postings were made online through social networks 
including Facebook and Twitter. As well, parents of youth who participated in a T1D-focused 
sports camp were contacted via email. Interested individuals were questioned regarding 
pubertal level and age of diabetes diagnosis. Based on parental or guardian report, if the study 
participants had not commenced puberty, were newly diagnosed with T1D, played hockey at a 
non-competitive level, played goalie, or were diagnosed with nervous system dysfunctions or 
retinopathy, they were excluded from the study. A teammate who does not have T1D was 
selected to function as a matched control participant. The control participants were similar in 
age, sex, height, body mass, and physical activity level. All study participants underwent 
identical measures. A schematic overview of the laboratory measures is presented in Figure 3. 
A total of 18 competitive, youth hockey players participated in the investigation; 12 
males and 6 females with and an age range of 13-17 (mean 14.7 ± 1.58). To screen for 
contraindications to completing vigorous exercise, all study participants completed evidence-
based 2013 PAR-Q+ and ePAR-med-X+ PA participation questionnaires (www.eparmedx.com). 
Minor assent forms were sent to study participants under 16 years, along with consent forms to 
parents or guardians, and study participants over the age of 16 were directly supplied with 
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informed consent forms. All forms were emailed to the study participants before visiting the 
laboratory, and were collected during their initial visit. All participants had a minimum of two 
visits to the laboratory. 
 
2.1.2  Visit One: Laboratory Physical and Physiological Fitness Assessments 
Anthropometric Data. Wearing light clothing and no shoes, body mass was measured 
using a digital scale (Seca Alpha, Germany). Height was measured without footwear using a 
wall-mounted stadiometer. BMI was calculated by dividing body mass in kilograms by height in 
meters squared. Waist circumference was measured using the National Institute of Health 
protocol, where the measuring tape is positioned horizontally on the skin, on the top border of 
the iliac crest. Bioelectrical impedance analysis (Tanita scale, model TBF-612, Arlington Heights, 
lll) was used to determine body fat percentage. Skinfold measurements were taken in 
accordance with the Canadian Physical Activity, Fitness and Lifestyle Approach (Gledhill & 
Jamnik, 2003 and the Physical Activity and Lifestyle “R” Medicine (Gledhill & Jamnik, 2012). 
Markings were made at the following skinfold sites: biceps, triceps, subscapula, iliac crest and 
medial calf, and measurements were made using Harpenden fat callipers. 
Anaerobic and Aerobic Fitness. To participate in both the anaerobic and aerobic fitness 
assessment, individuals with T1D were required to have a BG level between 5-15 mmol/L. BG 
was measured with the individual’s own hand held device. Individuals were allowed one 
attempt to correct BG levels if they were below the threshold by administering 16 grams of 
carbohydrate (4 tablets of Dex4). In contrast, if participants were above the BG threshold they 
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were instructed to consume water and take insulin if they deem that appropriate. Participants 
were asked to take a subsequent BG reading 15-30 minutes after their initial check and testing 
proceeded only if the BG levels were corrected. If the participants did not achieve the target 
range within 15-30 minutes, the laboratory testing was re-scheduled for another day.  
A 30-second Wingate protocol (Inbar, Bar-or, & Skinner, 1996) on a Monark Ergomedic 
894E Peak cycle ergometer was conducted to assess anaerobic fitness. Individuals’ seat heights 
were appropriately fitted allowing for a slight bend of 10-15 degrees of the knee joint during 
maximal extension. For each individual, resistance was calculated at 7.5% of their body mass. 
The ergometers were connected to a Monark software program that continuously recorded 
revolutions per minute (RPMs) and watts, which was used to determine peak, average and 
minimum power output, and fatigue index. A 5-minute warm-up on the cycle ergometer was 
allotted, during which the protocol was explained to the study participants by a qualified 
exercise professional administering the test. Participants were instructed to stay seated while 
pedaling as hard and as fast as possible for the full 30-seconds of the test. The verbal cues 
“faster, faster, go” were given prior to releasing the resistance to increase their pedalling 
frequency for the all-out sprint. These cues were used to ensure maximal pedaling cadence was 
achieved prior to applying the resistance, and verbal encouragements were given to the 
participants for the test duration. Immediately following the 30-second test, the resistance was 
removed, participants remained on the cycle ergometer to cool-down, and then were 
instructed to lie in a supine position for a 30-minute recovery period, where they were 
permitted to stretch and the athletes with T1D were directed to check their BG levels.  
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Aerobic fitness was assessed following the 30-minute rest period provided BG levels 
were stable and above 5mmol/L. Appropriate measures were taken if the BG values were 
below this level. A modified Astrand and Pollock (1978) incremental-to-maximum effort 
treadmill protocol was administered where both VO2max and HRmax were determined. Polar 
heart rate monitors were worn by the participants to obtain peak or maximum exercise HR. 
Participants were familiarized with the testing protocol and equipment during a brief warm up 
of walking on the treadmill. The protocol design incorporated multiple incremental 2-minute 
stages, where running speed and incline were progressively adjusted to increase intensity. All 
participants started the first stage at 3.5 mph (5.6 kph) at 0% incline, then proceeded to 5 mph 
(8.1 kph) at 0% incline, and then followed by 6.0 mph (9.7 kph) at 0% incline. Following the first 
3 stages the speed was adjusted based on individual running biomechanics, therefore some 
participants may have stayed at a speed of 6.0 mph (9.7 kph), while others were increased to 
6.5 (10.5 kph), 7 (11.3 kph), or 7.5 mph (12.1 kph). Once a comfortable running speed between 
6.0 (9.7 kph) and 7.5 mph (12.1 kph) was determined, the speed was kept constant and the 
intensity was increased by adjusting the incline for the duration of the test. The incline was 
increased by 2% for all of the following 2-minute stages. Verbal motivation was given to the 
participants to run for as many continuous stages as possible. When continuous running was no 
longer possible for the participant, the speed was adjusted to a walking speed for 2 minutes, 
marking the beginning of the discontinuous workloads to maximal (or supramaximal- see 
below) effort. During the discontinuous portion, participants ran at the speed determined 
during the continuous portion, while the incline was raised 2% higher than the previous 
workload. Each discontinuous stage lasted 2 minutes and was separated by 2 minutes of active 
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recovery (walking), this pattern continued for the duration of the test until VO2max was 
attained, that is the VO2 remained the same or dropped with increasing workloads (Gledhill, 
Cox, & Jamnik, 1994; Howley, Bassett, & Welch, 1995). Supramaximal testing represents high 
intensity exercise, specifically performed by an individual at workloads greater than that 
required to elicit VO2max (Crisafulli et al., 2004). Supramaximal workloads are widely used to 
confirm the attainment of VO2max during cardiovascular exercise testing (Astorino, White, & 
Dalleck, 2009). 
Indirect calorimetry, specifically open circuit spirometry, was used for the determination 
of VO2 and VO2max or VO2peak. Open circuit spirometry requires an individual to inhale air 
from the atmosphere and exhale air through a mouth-piece attached to a two-way valve (Ewald 
Koegal Co, San Antonio Texas), while wearing a nose plug. The two-way valve was attached to a 
hose, which was then connected to a 120L Tissotgasometer (Warren E Collins LTD. Braintree, 
Massachusetts). During the last 30 seconds of each incremental stage the fractional 
concentration of expired oxygen (FEO2) and carbon dioxide (FECO2), along with the volume of air 
expired was measured. Oxygen consumption (VO2) and carbon dioxide production (VCO2) was 
calculated for each workload using the recorded measurements (FEO2, FECO2, volume of air 
expired). Rapid response gas analyzers (Applied Electrochemistry, Model S-3A and CD-3S, 
Sunnyvale, California) were used to analyze the oxygen and carbon dioxide concentrations of 
the expired air. At the end of each incremental stage Rating of Perceived Exertion on a scale of 
6 to 20 (Borg, 1982) and HR were recorded. The VO2max test was terminated only if the 
participant could no longer complete a workload as a result of volitional fatigue, or if the 
qualified exercise professionals indicated that the participant reached their VO2max . 
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2.1.3  Visit Two: Laboratory Simulation Hockey Game Protocol 
Design. The “play” intervals during the laboratory simulated hockey game were based 
on the duration and intensity of HR monitored during play intervals throughout regular hockey 
games. Individuals wore a coded polar HR monitor during a regular on-ice hockey game. The 
recorded HR values were then examined to identify HR fluctuations throughout the games. 
Each sustained increase, or dip, in HR was analyzed for duration and intensity, as the HR was 
assumed to indicate a hockey shift involving skating sprints and stops during play, or a bench 
period between shifts respectively. A standardized laboratory-exercise protocol (Appendix D) 
was developed from the on-ice game information.  
The simulation hockey game protocol consisted of three 20-minute periods of 
intermittent high-intensity exercise separated by a 10-minute break period. Participants 
exercised on a Monark Ergomedic 894E Peak cycle ergometers, the same ergometer was used 
for the Wingate test, which were hooked up to laptop computers to measure RPMs and power 
output in Watts. Resistance was set at 5.25% of the participant’s body mass, or 70% of their 
Wingate resistance. The participants were verbally prompted to accelerate and decelerate their 
pedalling frequency using the cues “go,” “whistle” and “bench.” The term “go” was used to 
direct the participant to sprint on the ergometer with the same exertion they would during a 
hockey shift. “Whistle” signified a stoppage in play and the participants were permitted to sit 
stationary or pedal lightly with no resistance. Lastly, “bench” was used to indicate a prolonged 
break between shifts, during which participants rested without pedalling on the cycle 
ergometer. 
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Laboratory Game Simulation Procedures. Upon entering the laboratory, participants 
were instructed to treat the simulated hockey exercise similar to how they would during a 
regular game. Appropriate measures were taken to ensure BG levels were in the appropriate 
range before commencing game simulation. Whole BG concentration was measured with the 
individual’s own hand held device. Study participants were permitted one attempt to correct 
BG levels if they were below threshold by administering 16 grams of carbohydrate (4 tablets of 
Dex4), or consume a snack of choice with the same carbohydrate content. If participants were 
above the BG threshold upon entering the laboratory they were instructed to consume water 
and take insulin if deemed appropriate. A second BG reading was taken 15-30 minutes after 
their initial check. Participation in the laboratory hockey game simulation proceeded only if the 
individuals’ BG levels were corrected, if the individuals’ BG levels were not within the safe 
range the laboratory protocol was re-scheduled for another day.  
Before commencing the game simulation protocol, the participants were weighed and 
fitted with a Polar heart rate monitor and Fitmate VO2 max system (Image Monitoring). During 
the protocol HR, VO2, RPMs and Watts were continuosly monitored and recorded. At the end of 
each period, participants were given a 10-minute break where they were permitted to get off 
the cycle ergometer, walk around and stretch. At this time the individual with T1D checked 
their BG levels, and if at any time BG levels approached unsafe levels, 4 dextrose tablets were 
administered orally (16 grams of carbohydrate). The hockey game simulation protocol was 
followed by a cool-down. 
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Figure 3. Summary of Laboratory Measures 
 
 
 
2.1.4  Data and Statistical Analysis of the VO2 and HR Response  
The raw breath-by-breath VO2 and HR data measured via the Fitmate VO2max and Polar 
Heart Rate systems were time aligned to the start of exercise, with the onset of exercise 
defined as t = 0. The participants’ data for all three periods were then averaged over 
consecutive 10-second intervals to reduce noise and enhance the underlying characteristic.  
The resulting VO2 and HR data were then converted to be expressed as a percentage of VO2 
max (%VO2) and HRmax (%HR) for each participant. Finally, the nadir (minimum) and peak 
(maximum) VO2 and HR percentage values for each shift and bench intervals were also 
compiled for statistical analysis. 
The SPSS statistical software Version 20, was used for all the analysis, with a threshold 
for statistical significance set at p ≤ 0.05 a priori. Descriptive statistics (MSD) were calculated to 
Participants 
VO
2 
(mL∙Kg
-1
∙min
-1
) 
HR (bpm) 
RPM 
Watts 
Anthropometry 
Height 
(cm) 
Weight 
(Kg) 
Body 
Composition 
Laboratory Physical & Physiological  
Fitness Assessments 
Simulation Hockey 
Game Protocol 
Anaerobic 
Fitness 
30-Second 
Wingate 
Protocol 
VO
2 
max 
Incremental-
to-maximum 
Treadmill 
Protocol 
Aerobic 
Fitness 
Simulated 3 
period Hockey 
Game on Cycle 
Ergometer  
37 
 
summarize the participants’ anthropometric and physical plus physiological fitness 
characteristics. Independent samples t-tests were performed to assess any differences between 
the T1D and their matched controls for the various anthropometric, physical and physiologic 
variables where appropriate. Data collection errors in the Fitmate VO2max system resulted in 
incomplete data sets for 5 participants; therefore 13 participants were included in the final 
statistical analysis of VO2 and HR. An initial two-way repeated measures analysis of variance 
(ANOVA) was conducted using the group means of the raw %VO2 and %HR data to determine 
any group differences across the three periods. Prior to the analysis, the individual participants’ 
raw VO2 and HR data was converted to be expressed as a percentage of VO2 max and HRmax. 
Lastly, the mean differences of VO2 and HR, expressed as the mean nadir (minimum) and mean 
peak (maximum) values of percent VO2max and HRmax, were assessed using a two-way 
repeated measures analysis of variance (ANOVA) to determine if the VO2 and HR response 
differed across the three simulated hockey periods, and between the T1D and their matched 
controls. Sphericity tests were evaluated, and if necessary, the Greenhouse-Geiser method was 
used to adjust the degrees of freedom. The Bonferroni post-hoc comparison was used to locate 
specific pairwise differences between the three hockey game simulation periods. 
 
2.2  RESULTS 
2.2.1  Study Participants’ Characteristics 
In total, 12 males and 6 females participated in laboratory physical and physiological 
fitness assessments and simulated hockey game. Nine of the participants had T1D and each of 
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the nine had a control (ND) that was matched in age, sex, and physical plus physiological fitness 
level. All participants played competitive ice hockey; 4 at the A- level, 6 at the AA- level, and 8 
at the AAA- level, with the AAA- being the most competitive level. Descriptive statistics of the 
anthropometric and physical and physiological fitness profiles of the ice hockey players are 
reported in Table 1. According to an independent samples t-test, there were no significant 
differences between the T1D and ND groups in any of the anthropometric and physical plus 
physiological fitness measurements (p < 0.05). Participants’ age ranged from 13 to 17 years 
with a mean age of 14.7 ± 1.58. The mean relative VO2 max was 55.6 ± 5.7 mL·kg
-1·min-1 (range 
43.3-64.1) and the mean HRmax was 196.9 ± 6.6 bpm (range 186-209). Given the small number 
of female study participants no statistical analyses on sex differences were conducted. 
 
 
Table 2. Anthropometric and Physical plus Physiological Fitness Profiles of Competitive Youth 
Ice Hockey Players With and Without T1D (M ± SD). 
 T1D (n = 9) ND (n = 9) P value 
Age (yrs) 14.7 ± 1.58 14.7 ± 1.58 1.00 
Height (cm) 169.3 ± 7.7 170.1 ± 8.5 .841 
Weight (kg) 67.1 ± 8.6 66.2 ± 10.4 .850 
WC (cm) 77.0 ± 5.3 78.0 ± 6.1 .740 
Skinfolds (mm) 64.8 ± 22.6 52.2 ± 11.9 .185 
VO2max (mL·kg
-1·min-1) 54.6 ± 5.3 56.7 ± 6.2 .453 
HRmin (bpm) 53.8 ± 5.7 52.4 ± 8.4 .699 
HRmax (bpm) 196.7 ± 8.1 197.2 ± 5.2 .864 
Peak Power (Watts) 670.1 ± 148.9 716.1 ± 192.1 .579 
Peak Power (Watts/kg) 9.9 ± 1.4 10.7 ± 1.6 .318 
Fatigue (%) 46.4 ± 8.9 48.4 ± 9.6 .719 
*Significant difference between T1D and ND groups p < 0.05 
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Traditionally, VO2 kinetics has been analyzed by plotting and modeling the VO2 response 
using an exponential equation. In this investigation we chose to use a different approach, 
because of experimental conditions and technological limitations, as the traditional method 
was designed for investigating the VO2 kinetic response during constant-load exercise. The 
specific exponential equation (ΔVO2(t) = VO2(b) + A(1 – e
-t/T)) could not be applied to the HITT 
exercise performed in the present study, as the equation assumes that from baseline, VO2 
increases exponentially until a steady-state is achieved. The simple exponential function y = ex 
is used to model a relationship in which a constant change in the independent variable (in this 
case time) gives the same proportional change in the dependent variable (VO2). The simulation 
hockey game protocol was not a constant-load situation; within the 7 play shifts, the duration 
of the bouts of play and active rests continually varied. As well, the play shifts performed were 
not long enough in duration to achieve a steady-state VO2. Moreover, it was deemed unlikely 
that VO2 increased at the same rate during each play shift in each shift as there was a different 
amount of work being accomplished with each simulated play shift (e.g. 30s of work vs 10s vs 
40s). As such, VO2 could not be compared across the play shifts. Therefore, we chose to analyse 
the VO2 and HR response simply by plotting and representing the data as a percentage of 
measured VO2max and HRmax and using the nadir, mean and peak values from the play shifts 
to identify a possible unique response.  
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2.2.2  Laboratory Simulation Hockey Game Protocol 
The study participants with T1D attended the laboratory sessions along with their paired 
ND teammate. The pairs completed the simulation hockey game protocol in tandem which 
consisted of three 20-minute periods, each separated by 10 minute of non-exercise rest. During 
rest, all participants were allowed to walk around. As well, the participants with T1D were 
directed to check their BG and consume dextrose tablets if required.  
Prior to starting the simulation hockey game protocol, two participants with T1D had BG 
levels below the 5 mmol/L safety cut-off, and therefore were treated with either 16 grams of 
dextrose or a self-supplied snack (comparable to what they would consume during an ice 
hockey game their  BG was low). The single attempt to correct BG was successful for both 
participants and the hockey game simulation protocol proceeded. During the simulation hockey 
game, one participant with T1D required dextrose supplementation because of low BG levels 
(<5 mmol/L). VO2 and HR recordings were completed for 13 individuals (7 T1D, and 6 ND). One 
participant in the T1D group was unable to complete the first period of the simulation hockey 
game resulting in incomplete recordings for this individual and their paired ND control. For 
three other individuals, incomplete data recordings were due to limitations of the equipment, 
where the Fitmate VO2 system stopped recording part way through a 20-minute period, or 
failed to record VO2 and HR entirely. VO2 and HR data from 13 completed recordings for period 
1 of the simulation hockey game are represented in Figure 4. During the initial shift, it was 
observed that VO2 and HR increased rapidly from approximately 20% to 80% and approximately 
55% to 90% respectively during the first 80 seconds of period 1. In each of the subsequent shifts 
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within the period VO2 ranged from 50% to 80% of VO2max, and HR ranged from 75% to 90% of 
HRmax. 
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Figure 4. 10-Second averaged percentage of VO2max and HRmax during the first 20-minute 
period of the simulation hockey game with playing shifts highlighted for all of the study 
participants (M ± SE). 
 
 
 
The shaded areas represent the 7 shifts within the periods which consist of play sprints and 
active recovery. The white areas represent the 6 bench intervals within the periods that 
involved passive rest. The red and green dashed lines represent the standard error for VO2 and 
HR. Within the first period VO2 ranged between 20% and 80% of VO2max and HR ranged 
between 55% and 90% of HRmax. 
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2.2.3   Raw Data 
 An initial two-way ANOVA with repeated measures on the mean breath-by-breath 
%VO2max and %HRmax was conducted. Table 3 contains the mean breath-by-breath %VO2max 
and %HRmax between the two groups for all 3 periods of the simulation hockey game. Figure 5 
illustrates the comparison of %VO2max between the individuals with and without T1D. There 
was no significant difference in the mean %VO2max between the groups during the simulation 
hockey game (F(1.11) = 0.06, p > 0.05). Figure 6 illustrates the % HRmax comparison between 
the individuals with and without T1D. The analysis of %HRmax indicated that there were no 
significant differences in the mean %HRmax between the two groups of participants (F(1,11) = 
0.06, p > 0.05).  
 
Table 3. The mean breath-by-breath %VO2max and %HRmax for all 3 periods of the simulation 
hockey game for competitive youth ice hockey players with and without T1D (M ± SE). 
 % VO2max % HRmax 
 T1D (n=7) ND (n=6) T1D (n=7) ND (n=6) 
Period 1 55.6 ± 3.5 57.1 ± 3.8 82.3 ± 1.0 82.0 ± 1.1 
Period 2 52.6 ± 4.1 53.0 ± 4.4 82.5 ± 1.1 82.3 ± 1.2 
Period 3 54.2 ± 4.4 56.4 ± 4.7 82.2 ± 1.3 81.5 ± 1.4 
There were no significant differences between groups p < 0.05 
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Figure 5.  Comparing the mean %VO2max during 3 periods of a simulation hockey game 
between competitive youth ice hockey players with and without T1D (M ± SE). 
 
 
 
 
 
There are no significant differences (p > 0.05) in the mean %VO2max between the T1D and ND 
groups. Mean values and standard error bars are included. During the 3 periods all of the 
participants are working at approximately 55% of their VO2max. 
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Figure 6. Comparing the mean %HRmax during periods of a simulation hockey game between 
competitive youth ice hockey players with and without T1D (M ± SE). 
 
 
 
There are no significant differences (p > 0.05) in the mean %HRmax between the T1D and ND 
groups. Mean values and standard error bars are included. During the 3 periods all of the 
participants are working at approximately 82% of their HRmax. 
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In addition to the between groups analysis, a within group between periods analysis was 
also conducted for the mean breath-by-breath %VO2max and %HRmax data. Table 4 
summarizes the mean and standard error for %VO2max and %HRmax between the 3 periods for 
the groups individually. Figure 7 illustrates the mean %VO2max displayed in 10-second averaged 
intervals across the 3 simulation hockey periods. There was no significant difference observed 
in the mean %VO2max between the 3 periods for both groups (F(2,22) = 3.29, p > 0.05). Figure 8 
illustrates the mean %HRmax displayed in 10-second averaged intervals across the 3 simulation 
hockey periods. There was no significant difference observed in the mean %HRmax between 
the 3 periods for both groups (F(1.19,13.12) = 0.27, p > 0.05). Both the T1D and ND groups 
worked at approximately 55% and 82% of their VO2max and HRmax respectively, throughout 
the 60-minute simulation hockey game. 
 
Table 4.The mean breath-by-breath %VO2max and %HRmax between periods of a simulation 
hockey game for competitive youth ice hockey players with and without T1D (M ± SE). 
%VO2max 
 
  
Mean ± SE 
 
T1D(n=7) Period 1 55.6 ± 3.5  
Period 2 52.6 ± 4.1  
Period 3 54.2 ± 4.4  
ND (n=6) Period 1 57.1 ± 3.8  
Period 2 53.0 ± 4.4  
Period 3 56.4 ± 4.7  
%HRmax    
T1D(n=7) Period 1 82.3 ± 1.0  
Period 2 82.5 ± 1.1  
Period 3 82.2 ± 1.3  
ND (n=6) Period 1 82.0 ± 1.1  
Period 2 82.3 ± 1.2  
Period 3 81.5 ± 1.4  
There were no significant differences between periods p > 0.05 
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Figure 7a. 10-Second average oxygen consumption expressed relative to VO2max across all 3 
periods of a 60-minute simulation hockey game for competitive youth ice hockey players with 
and without T1D. Plotted without the standard error. 
There are no differences in %VO2max between periods 1, 2 and 3 for the T1D and ND groups (p 
> 0.05). The %VO2max is fairly consistent between periods 1, 2 and, and ranges between 20% 
and 90% for both groups. It is evident that the individuals with and without T1D are able to 
perform a longer duration of HITT without fatiguing. 
 
Figure 7b. 10-Second average oxygen consumption expressed relative to VO2max across all 3 
periods of a 60-minute simulation hockey game for competitive youth ice hockey players with 
and without T1D. Plotted with the standard error (M ± SE). 
The standard error is represented by the dashed black and red lines for the T1D and ND groups 
respectively. There are no differences in %VO2max between periods 1, 2 and 3 for the T1D and 
ND groups (p > 0.05). The %VO2max is fairly consistent between periods 1, 2 and, and ranges 
between 20% and 90% for both groups. It is evident that the individuals with and without T1D 
are able to perform a longer duration of HITT without fatiguing. 
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Figure 8a. 10-Second average heart rate expressed relative to HRmax across all 3 periods of a 
60-minute simulation hockey game for competitive youth ice hockey players with and without 
T1D. Plotted without the standard error. 
There are no differences in %HRmax between periods 1, 2 and 3 for the T1D and ND groups. It 
is illustrated that the %HRmax remains consistent between periods 1, 2 and 3. %HRmax ranges 
between 60% and 90% for both groups of participants. 
 
Figure 8b. 10-Second average heart rate expressed relative to HRmax across all 3 periods of a 
60-minute simulation hockey game for competitive youth ice hockey players with and without 
T1D. Plotted with the error bars (M ± SE). 
The standard error is represented by the dashed blue and orange lines for the T1D and ND 
groups respectively. There are no differences in %HRmax between periods 1, 2 and 3 for the 
T1D and ND groups. It is illustrated that the %HRmax remains consistent between periods 1, 2 
and 3. %HRmax ranges between 60% and 90% for both groups of participants. 
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2.2.4  Averaged Nadir and Peak %VO2max and %HRmax During the Play Shift Intervals  
Further analyses were conducted on the means of the nadir and peak %VO2max and 
%HRmax values for each play shift and bench intervals using the 10-second averaged data. A 
two-way ANOVA with repeated measures was used to determine if significant mean differences 
in the resting (resting VO2 expressed as a percentage of VO2max), average nadir and the 
average peak values of %VO2max and %HRmax were present between the T1D and ND groups 
at rest and during play shift and bench intervals. In addition, the two-way ANOVA with 
repeated measures was used to reveal any significant mean differences in the rest, average 
nadir and the average peak values of %VO2max and %HRmax across the 3 periods for the T1D 
and ND groups individually. 
Table 5 summarizes the means and standard errors for the average nadir and the 
average peak %VO2max from the pairwise comparison between the T1D and ND groups. There 
are no significant differences in either of the average nadir and the average peak %VO2max 
between the T1D and ND individuals at rest, or during any of the 7 play shift and 6 bench 
intervals during the 3 periods (Figure 9). The individuals with T1D are able to achieve similar 
high range %VO2max values, 70-90% of VO2max, compared with the ND during the 7 play shift 
intervals across all 3 periods. 
Table 6 summarizes the means and standard errors for the average nadir and the 
average peak %HRmax from the pairwise comparison between the T1D and ND groups. The 
analyses indicated that there were no significant differences in both the average nadir and the 
average peak %HRmax between the T1D and ND groups at rest, or during any of the 7 play shift 
and 6 bench intervals within the 3 periods (Figure 10). Across the 3 periods similar %HRmax 
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high values, 80-95% of HRmax, between the T1D and ND individuals were reached during the 7 
play shift intervals. 
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Table 5. Comparison of the average oxygen consumption expressed relative to VO2max at the 
beginning and end of each play shift and bench interval during a 60-minute simulation hockey 
game between competitive youth ice hockey players with and without T1D (M ± SE). 
  Period 1 Period 2 Period 3 
  T1D (n=7) ND (n=6) T1D (n=7) ND (n=6) T1D (n=7) ND (n=6) 
Rest  0.19 ± 0.027 0.18 ± 0.181 0.30 ± 0.049 0.24 ± 0.243 0.20 ± 0.028 0.18 ± 0.177 
Shift 
1 
High 0.80 ± 0.052 0.85 ± 0.057 0.76 ± 0.055 0.78 ± 0.059 0.78 ± 0.055 0.77 ± 0.059 
Low 0.41 ± 0.050 0.47 ± 0.054 0.40 ± 0.037 0.42 ± 0.040 0.37 ± 0.038 0.38 ± 0.041 
Bench 
1 
High 0.66 ± 0.052 0.62 ± 0.056 0.67 ± 0.038 0.62 ± 0.042 0.60 ± 0.048 0.65 ± 0.052 
Low 0.26 ± 0.029 0.28 ± 0.031 0.27 ± 0.030 0.25 ± 0.033 0.23 ± 0.015 0.23 ± 0.016 
Shift 
2 
High 0.77 ± 0.050 0.83 ± 0.054 0.74 ± 0.059 0.76 ± 0.064 0.80 ± 0.050 0.83 ± 0.054 
Low 0.48 ± 0.029 0.48 ± 0.031 0.48 ± 0.030 0.40 ± 0.033 0.45 ± 0.015 0.51 ± 0.016 
Bench 
2 
High 0.66 ± 0.053 0.72 ± 0.057 0.62 ± 0.053 0.64 ± 0.057 0.63 ± 0.061 0.68 ± 0.065 
Low 0.45 ± 0.027 0.40 ± 0.029 0.38 ± 0.035 0.38 ± 0.038 0.37 ± 0.037 0.41 ± 0.040 
Shift 
3 
High 0.83 ± 0.038 0.87 ± 0.041 0.78 ± 0.062 0.81 ± 0.067 0.82 ± 0.041 0.86 ± 0.044 
Low 0.60 ± 0.037 0.61 ± 0.040 0.47 ± 0.040 0.55 ± 0.043 0.54 ± 0.040 0.59 ± 0.043 
Bench 
3 
High 0.65 ± 0.049 0.66 ± 0.053 0.56 ± 0.049 0.66 ± 0.053 0.64 ± 0.056 0.72 ± 0.061 
Low 0.19 ± 0.017 0.18 ± 0.019 0.17 ± 0.021 0.17 ± 0.023 0.18 ± 0.019 0.17 ± 0.021 
Shift 
4 
High 0.77 ± 0.052 0.89 ± 0.056 0.74 ± 0.060 0.80 ± 0.065 0.79 ± 0.056 0.84 ± 0.061 
Low 0.44 ± 0.038 0.49 ± 0.041 0.36 ± 0.052 0.40 ± 0.056 0.39 ± 0.044 0.40 ± 0.048 
Bench 
4 
High 0.68 ± 0.049 0.69 ± 0.052 0.64 ± 0.050 0.66 ± 0.053 0.65 ± 0.059 0.69 ± 0.063 
Low 0.48 ± 0.039 0.46 ± 0.043 0.41 ± 0.021 0.45 ± 0.023 0.38 ± 0.026 0.46 ± 0.028 
Shift 
5 
High 0.81 ± 0.038 0.84 ± 0.041 0.83 ± 0.051 0.79 ± 0.055 0.81 ± 0.040 0.87 ± 0.043 
Low 0.63 ± 0.038 0.54 ± 0.041 0.55 ± 0.048 0.53 ± 0.052 0.57 ± 0.061 0.60 ± 0.066 
Bench 
5 
High 0.64 ± 0.055 0.66 ± 0.060 0.59 ± 0.060 0.65 ± 0.065 0.64 ± 0.054 0.66 ± 0.059 
Low 0.23 ± 0.022 0.25 ± 0.024 0.20 ± 0.019 0.22 ± 0.020 0.21 ± 0.022 0.21 ± 0.024 
Shift 
6 
High 0.71 ± 0.065 0.67 ± 0.070 0.76 ± 0.062 0.77 ± 0.067 0.74 ± 0.057 0.76 ± 0.061 
Low 0.37 ± 0.048 0.46 ± 0.052 0.50 ± 0.042 0.44 ± 0.045 0.45 ± 0.048 0.49 ± 0.052 
Bench 
6 
High 0.61 ± 0.041 0.58 ± 0.044 0.62 ± 0.043 0.65 ± 0.047 0.65 ± 0.064 0.67 ± 0.069 
Low 0.35 ± 0.032 0.36 ± 0.034 0.37 ± 0.034 0.39 ± 0.037 0.35 ± 0.036 0.38 ± 0.038 
Shift 
7 
High 0.80 ± 0.039 0.84 ± 0.043 0.81 ± 0.045 0.86 ± 0.049 0.85 ± 0.049 0.87 ± 0.053 
Low 0.47 ± 0.032 0.43 ± 0.035 0.46 ± 0.034 0.46 ± 0.037 0.45 ± 0.044 0.47 ± 0.048 
There were no significant differences between groups p > 0.05 
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Table 6. Comparison of the average heart rate expressed relative to HRmax at the beginning 
and end of each play shift and bench interval during a 60-minute simulation hockey game 
between competitive youth ice hockey players with and without T1D (M ± SE). 
  Period 1 Period 2 Period 3 
  T1D (n=7) ND (n=6) T1D (n=7) ND (n=6) T1D (n=7) ND (n=6) 
REST  0.59 ± 0.043 0.52 ± 0.521 0.72 ± 0.026 0.67 ± 0.670 0.64 ± 0.020 0.62 ± 0.624 
Shift 
1 
High 0.87 ± 0.018 0.87 ± 0.020 0.91 ± 0.012 0.90 ± 0.013 0.91 ± 0.016 0.89 ± 0.018 
Low 0.71 ± 0.030 0.69 ± 0.033 0.76 ± 0.024 0.76 ± 0.026 0.75 ± 0.020 0.73 ± 0.021 
Bench 
1 
High 0.86 ± 0.023 0.85 ± 0.025 0.89 ± 0.011 0.90 ± 0.012 0.89 ± 0.012 0.89 ± 0.012 
Low 0.62 ± 0.034 0.63 ± 0.036 0.69 ± 0.023 0.68 ± 0.025 0.64 ± 0.020 0.65 ± 0.022 
Shift 
2 
High 0.86 ± 0.025 0.88 ± 0.027 0.91 ± 0.012 0.89 ± 0.013 0.90 ± 0.010 0.89 ± 0.011 
Low 0.72 ± 0.035 0.76 ± 0.038 0.78 ± 0.024 0.76 ± 0.025 0.78 ± 0.018 0.76 ± 0.019 
Bench 
2 
High 0.90 ± 0.011 0.89 ± 0.011 0.90 ± 0.014 0.89 ± 0.015 0.90 ± 0.015 0.89 ± 0.016 
Low 0.78 ± 0.011 0.79 ± 0.012 0.78 ± 0.020 0.78 ± 0.022 0.75 ± 0.025 0.76 ± 0.027 
Shift 
3 
High 0.92 ± 0.008 0.91 ± 0.009 0.92 ± 0.011 0.91 ± 0.012 0.92 ± 0.012 0.91 ± 0.013 
Low 0.82 ± 0.011 0.83 ± 0.012 0.82 ± 0.018 0.81 ± 0.020 0.81 ± 0.019 0.79 ± 0.021 
Bench 
3 
High 0.90 ± 0.006 0.90 ± 0.007 0.88 ± 0.015 0.90 ± 0.016 0.92 ± 0.011 0.90 ± 0.012 
Low 0.63 ± 0.018 0.63 ± 0.020 0.63 ± 0.018 0.65 ± 0.020 0.64 ± 0.018 0.62 ± 0.020 
Shift 
4 
High 0.93 ± 0.032 0.88 ± 0.034 0.92 ± 0.011 0.92 ± 0.011 0.91 ± 0.013 0.91 ± 0.014 
Low 0.76 ± 0.038 0.71 ± 0.041 0.75 ± 0.023 0.75 ± 0.025 0.77 ± 0.016 0.74 ± 0.018 
Bench 
4 
High 0.92 ± 0.009 0.92 ± 0.009 0.89 ± 0.012 0.91 ± 0.013 0.90 ± 0.015 0.92 ± 0.016 
Low 0.83 ± 0.014 0.84 ± 0.015 0.79 ± 0.016 0.82 ± 0.018 0.76 ± 0.019 0.79 ± 0.021 
Shift 
5 
High 0.93 ± 0.011 0.93 ± 0.012 0.93 ± 0.011 0.92 ± 0.012 0.92 ± 0.014 0.92 ± 0.015 
Low 0.83 ± 0.027 0.85 ± 0.029 0.86 ± 0.014 0.84 ± 0.015 0.82 ± 0.020 0.82 ± 0.022 
Bench 
5 
High 0.92 ± 0.015 0.92 ± 0.016 0.88 ± 0.017 0.90 ± 0.018 0.91 ± 0.013 0.90 ± 0.014 
Low 0.66 ± 0.031 0.68 ± 0.033 0.67 ± 0.016 0.67 ± 0.018 0.65 ± 0.020 0.66 ± 0.021 
Shift 
6 
High 0.87 ± 0.019 0.83 ± 0.020 0.88 ± 0.011 0.87 ± 0.011 0.87 ± 0.015 0.86 ± 0.017 
Low 0.78 ± 0.019 0.77 ± 0.021 0.80 ± 0.020 0.76 ± 0.022 0.80 ± 0.019 0.78 ± 0.021 
Bench 
6 
High 0.87 ± 0.016 0.86 ± 0.017 0.89 ± 0.010 0.88 ± 0.010 0.90 ± 0.016 0.89 ± 0.018 
Low 0.75 ± 0.022 0.75 ± 0.024 0.76 ± 0.016 0.77 ± 0.018 0.74 ± 0.029 0.75 ± 0.031 
Shift 
7 
High 0.93 ± 0.012 0.91 ± 0.012 0.91 ± 0.018 0.92 ± 0.019 0.93 ± 0.013 0.92 ± 0.014 
Low 0.80 ± 0.019 0.79 ± 0.020 0.82 ± 0.015 0.83 ± 0.016 0.81 ± 0.024 0.81 ± 0.026 
There were no significant differences between groups p > 0.05 
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Figure 9a. Comparison of the nadir oxygen consumption rate expressed relative to VO2max, at 
the beginning and end of each play shift and bench interval during a 60-minute simulation 
hockey game between individuals with and without T1D (M ± SE). 
 
The filled circles and squares represent the nadir %VO2max for the T1D and ND groups 
respectively. There are no significant differences in %VO2max between the T1D and ND group 
observed in the 7 play shift and 6 bench intervals during any of the 3 periods (p > 0.05). The 
nadir %VO2max is similar between individuals with and without T1D. Nadirs range from 30-60% 
of VO2max for the individuals with and without T1D during the 7 play shifts for the 3 periods. 
 
Figure 9b. Comparison of the peak oxygen consumption rate expressed relative to VO2max, at 
the beginning and end of each play shift and bench interval during a 60-minute simulation 
hockey game between individuals with and without T1D (M ± SE). 
 
The open circles and squares represent the peak %VO2max for the T1D and ND groups 
respectively. There are no significant differences in %VO2max between the T1D and ND group 
observed in the 7 play shift and 6 bench intervals during any of the 3 periods (p > 0.05). The 
peak %VO2max is similar between individuals with and without T1D. Peaks range from 70-90% 
of VO2max for the individuals with and without T1D during the 7 play shifts for the 3 periods. 
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Figure 10a. Comparison of the nadir heart rate expressed relative to HRmax, at the beginning 
and end of each play shift and bench interval during a 60-minute simulation hockey game 
between individuals with and without T1D (M ± SE). 
 
The filled triangles and circles represent the nadir %HRmax for the T1D and ND groups 
respectively. There are no significant differences in %HRmax between the T1D and ND group 
observed in the 7 play shift and 6 bench intervals during any of the 3 periods (p > 0.05). The 
nadir %HRmax is similar between individuals with and without T1D. Nadirs range from 70-85% 
of HRmax for the individuals with and without T1D during the 7 play shifts for the 3 periods. 
 
Figure 10b. Comparison of the peak heart rate expressed relative to HRmax, at the beginning 
and end of each play shift and bench interval during a 60-minute simulation hockey game 
between individuals with and without T1D (M ± SE). 
 
The open triangles and circles represent the peak %HRmax for the T1D and ND groups 
respectively. There are no significant differences in %HRmax between the T1D and ND group 
observed in the 7 play shift and 6 bench intervals during any of the 3 periods (p > 0.05). The 
peak %HRmax is similar between individuals with and without T1D. Peaks range from 80-95% of 
HRmax for the individuals with and without T1D during the 7 play shifts for the 3 periods. 
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Looking at the T1D and ND groups separately, there were some significant differences in 
the average nadir and the average peak %VO2max and %HRmax values between the three 
periods for both groups. The Bonferroni post hoc analysis revealed that there were no 
significant differences between the periods in the mean resting %VO2max (resting VO2 
expressed as a percentage of VO2max) for the T1D and ND groups, however the mean resting 
%HRmax (resting HR expressed as a percentage of HRmax) was shown to be significantly 
different in both of the groups (Table 7). For the T1D group the mean resting expressed as a 
%HRmax, was significantly lower in period 1 compared with period 2 (p < 0.01), was 
significantly higher in period 2 compared to period 3 (p < 0.01), but no differences were 
observed between periods 1 and 3 (p = 0.756). In the ND group the mean resting %HRmax 
during period 1 was significantly lower from period 2 (p < 0.01), and no differences were 
revealed between periods 2 and 3 (p = 0.137), as well as periods 1 and 3 (p = 0.135). 
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Table 7. Mean resting oxygen consumption expressed relative to VO2max and mean resting 
heart expressed relative to HRmax between periods for competitive youth ice hockey players 
with and without T1D (M ± SE). 
Resting 
%VO2max 
 Mean ± SE  
T1D(n=7) Period 1 19.4 ± 2.698  
Period 2 29.9 ± 4.883  
Period 3 20.4 ± 2.795  
ND (n=6) Period 1 18.1 ± 2.915  
Period 2 24.3 ± 5.274  
Period 3 17.7 ± 3.019  
Resting 
%HRmax 
   
T1D(n=7) Period 1 58.5 ± 4.307 +  
Period 2 71.7 ± 2.574 +‡  
Period 3 63.6 ± 2.020 ‡  
ND (n=6) Period 1 52.1 ± 4.652 +  
Period 2 67.0 ± 2.780 +  
Period 3 62.4 ± 2.181  
+ p < 0.01Significant difference between periods 1 and 2 
‡ p < 0.01 Significant difference between periods 2 and 3 
† p < 0.01 Significant difference between periods 1 and 3 
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Figures 11 and 12 depict the differences in the average nadir and average peak 
%VO2max values during each play shift and bench intervals for the T1D and ND groups 
respectively between the three periods. During the simulation hockey game protocol there 
were significant differences in average nadir %VO2max values between the periods for the T1D 
group during the 3rd play shift and bench intervals 2 and 4 respectively (p < 0.05). For this same 
group, significant differences in the average peak %VO2max values were noted between 
periods in the 2nd and 4th play shifts, plus the 3rd bench interval (p < 0.05). In the ND group 
significant differences in the average peak %VO2max values were noted during the 2
nd play shift 
(p < 0.05). The differences observed in the average nadir and the average peak %VO2max values 
for both the T1D and ND groups are likely due to the participants’ self-selected pacing 
throughout the play shifts and active rest intervals throughout the simulation hockey game.  
Specific group differences in the average nadir and the average peak %HRmax values for 
each play shift and bench interval between the 3 periods are illustrated in Figures 11 and 12. 
The analysis revealed that the average nadir %HRmax values were significantly different 
between the periods in the T1D group during the 1st and 4th bench intervals, and the average 
peak %HRmax values were only different between periods during the 4th bench interval (p < 
0.05). In the ND group, the average nadir %HRmax values were shown to be significantly 
different during the 3rd bench interval, however there were no significant differences in the 
average peak %HRmax values between any of the periods in this group (p < 0.05). Similar to the 
%VO2max, the differences observed in the average nadir and the average peak %HRmax values 
for both the T1D and ND groups are likely due to individuals’ self-selected pacing during the 
play shifts and active rest intervals throughout the simulation hockey game.  
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Figure 11. T1D group differences in the average nadir and peak oxygen consumption rate and 
the average nadir and peak heart rate, expressed relative to VO2max and HRmax respectively, 
between periods in a 60-minute simulation hockey game (M ± SE). 
A C  
B D  
+ p < 0.05 Significant difference between periods 1 and 2 
‡ p < 0.05 Significant difference between periods 2 and 3 
† p < 0.05 Significant difference between periods 1 and 3 
 
 
 
Average nadir and peak %VO2max and % HRmax values for all participants with T1D (n=7) for a 
60 minute hockey game simulation protocol between periods.  Some significant differences 
were shown in some of the play shift and bench intervals.  Panel A. Shows the differences in 
average peak %VO2 values for all play shift and bench intervals between periods.  Panel B. 
Shows the differences in average nadir %VO2max values for all play shift and bench intervals 
between periods.  Panel C. Shows the differences in average peak %HRmax values for all play 
shift and bench intervals between periods. Panel D. Shows the differences in average nadir 
%HRmax values for all play shift and bench intervals between periods. The differences observed 
in the average nadir and peak %VO2max and %HRmax values for the participants with T1D are 
most likely due to the individuals’ self-selected pacing during the play shifts and active intervals 
rest during each period. 
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Figure 12. ND group differences in the average nadir and peak oxygen consumption rate and 
the average nadir and peak heart rate, expressed relative to VO2max and HRmax respectively, 
between periods in a 60-minute simulation hockey game (M ± SE). 
A C  
B D  
+ p < 0.05 Significant difference between periods 1 and 2 
‡ p < 0.05 Significant difference between periods 2 and 3 
† p < 0.05 Significant difference between periods 1 and 3 
 
 
 
Average nadir and peak %VO2max and %HRmax values for all ND participants (n=6) for a 60-
minute hockey game simulation protocol between periods.  Some significant differences were 
shown in some of the play shift and bench intervals.  Panel A. Shows the differences in average 
peak %VO2max values for all play shift and bench intervals between periods.  Panel B. Shows 
the differences in average nadir %VO2max values for all play shift and bench intervals between 
periods.  Panel C. Shows the differences in average peak %HRmax values for all play shift and 
bench intervals between periods. Panel D. Shows the differences in average nadir %HRmax 
values for all play shift and bench intervals between periods. The differences observed in the 
average nadir and peak %VO2max and %HRmax values for the ND are most likely due to the 
individuals’ self-selected pacing during the play shifts and active rest intervals during each 
period. 
 
60 
 
2.3  DISCUSSION 
 The primary purpose of this study was to examine and compare the VO2 and HR 
responses in a simulation hockey game protocol between a population of young, competitive 
athletes with and without T1D. The study outcomes revealed that highly active youth with 
uncomplicated T1D whose glycaemia is well controlled have similar physical plus physiological 
fitness levels and exercise tolerances to their matched ND controls in response to HITT. 
Remarkably, there were no significant differences in the VO2max, or in the average nadir, mean 
and average peak %VO2max and %HRmax responses between the T1D and ND groups during 
the simulation hockey game. Some significant differences were noted in the average nadir and 
average peak %VO2max and %HRmax responses between the three periods for both the T1D 
and ND groups individually. These observed differences during the simulation hockey game 
were not consistent between the periods and were observed in both groups. Therefore, we can 
postulate that the random differences observed during the simulation hockey game (HITT) were 
not due to diabetes related influence on the response, but more likely due to self-selected 
pacing differences between the participants during the play shift intervals. 
The results of this study build on those previously published supporting no differences in 
the maximal aerobic capacity between T1D and ND populations. Mosher et al. 1998, reported 
that physically inactive adolescents with T1D (17.2 ± 1.2yrs) have similar VO2max values when 
compared with physically inactive ND adolescents (19.4 ± 1.3yrs). The investigators measured 
VO2 before and after implementing a 12-week exercise training program, and found that both 
groups improved their cardiovascular endurance with no differences in VO2max between 
individuals with and without T1D, pre and post training (T1D: Pre- 40.5 ± 5.8, Post- 44.8 ± 5.2 
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mL·kg-1·min-1 compared with ND: Pre- 41.6 ± 6.7, Post- 46.6 ± 7.2 mL·kg-1·min-1). Mosher et al. 
(1998) found that adolescents with T1D respond similarly to an aerobic exercise training 
program in comparison with ND, which may suggest that the VO2 kinetics would respond to 
training in a similar way. Unfortunately the investigators did not measure the VO2 kinetics and 
HR responses so the influence of training on the rate of change for VO2 was not determined. 
Veves et al. (1997) investigated groups of participants with complicated and 
uncomplicated T1D. Five groups of participants aged 30-40 years were included in the study. 
Three exercise groups: a control group (CE), a group with T1D (DE), and a neuropathy group 
with T1D (NDE), who all performed greater than 10 hrs/wk of endurance exercise. Two 
sedentary groups one control group without T1D(CS) and one group with T1D (DS). The 
investigators found that the participants with T1D had similar aerobic capacities to ND 
individuals with similar exercise histories (CE- 56.8 ± 9.1 vs. DE- 54.0 ± 8.1 mL·kg-1·min-1, CS- 
38.7 ± 6.0 vs. DS- 36.7 ± 9.6 mL·kg-1·min-1). The NDE group had a significantly lower VO2max 
(42.0 ± 11.6 mL·kg-1·min-1) in comparison with the CE and DE groups. HRmax was also measured 
and there were no differences between CE- 184 ± 12 vs. DE- 186 ± 3 bpm and CS- 187 ± 11 vs. 
DS- 181 ± 3 bpm. The authors concluded that in the absence of neuropathy, individuals with 
uncomplicated T1D are able to reach the same VO2max and HRmax as similarly trained ND. Our 
results are in line with this since none of our participants with T1D had neuropathy. 
In the present investigation, the measured VO2max values for the ND and T1D groups 
were 56.7 ± 8.4 mL·kg-1·min-1and 54.6 ± 5.3 mL·kg-1·min-1respectively. These VO2max values in 
this investigation are similar to the athletic groups CE- 56.8 ± 9.1 and DE- 54.0 ± 8.1 mL·kg-1·min-
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1 found in the investigation by Veves et al. (1997) despite the age difference in the study 
participant cohorts. The HRmax of the athletic groups in Veves at al. (1997) study are 
substantially lower CE- 184 ± 12 and DE- 186 ± 3 bpm, than those found in the present 
investigation ND- 197.2 ± 5.2 and T1D- 196.7 ± 8.1 bpm, but this could be partially attributed to 
the protocol that Veves et al. employed to attain the VO2max values. It is generally assumed 
that the T1D population have significantly lower aerobic fitness levels compared to the healthy 
ND population. However, it seems that with equivalent exercise histories persons with 
uncomplicated T1D are able to achieve similar high range VO2max and HRmax values as their 
ND counterparts, indicating comparable exercise capacities and trainability responses. 
It is important to note that studies have reported more consistently that individuals with 
T1D have lower exercise tolerances in comparison with ND (Chu et al., 2011; Komatsu et al., 
2005; Masuda & Sato, 1989; Metcaf et al., 2014; Nadeau et al., 2010; Poortmans et al., 1986; 
Riddell & Perkins, 2006; Robertson et al., 2009; Wanke et al., 1992; Williams et al., 2011). A 
possible explanation for this inconsistency in the literature may be due to of the select 
population investigators recruited. Many fail to assess the habitual non-exercise plus exercise 
physical activity patterns in young persons with T1D prior to study commencement, as well as 
focus on non-athletic populations. Consequently, their conclusions regarding lower aerobic 
endurance and exercise tolerance in individuals with T1D may not be related to diabetes per se, 
but in fact due to a lower physical plus physiological fitness level to begin with (Brandenburg et 
al., 1999). Mentioned previously, the investigators Arslanian et al., (1990), Austin et al., (1993), 
Faulkner (2010), Komatsu et al., (2005) and Wanke et al., (1992) reported low VO2 measures 
ranging from 34- 41 mL·kg-1·min-1 in youth with T1D. (Arslanian: T1D- 34.9 ± 8.6 vs ND- 38.6± 
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9.9 mL·kg-1·min-1; Austin: T1D- 33.7 ± 7.0 vs ND- 41.0 ± 10.4 mL·kg-1·min-1 [matched for age, 
BMI, and Tanner stage]; Faulkner: T1D- 34.7 ± 8.9 vs T2D- 25.4 ± 5.9 mL·kg-1·min-1; Komatsu: 
T1D- 41.57 ± 7.68 vs ND- 51.12 ± 9.94 mL·kg-1·min-1; Wanke: T1D- 2.56 ± 0.71 vs ND- 3.17 ± 0.77 
L·min-1). With one exception, there was no mention of PA histories or matching participants for 
PA levels in any of these studies, therefore it is assumed that these investigators failed to assess 
habitual exercise and non-exercise PA patterns in their participants. Faulkner (2010) was the 
only investigator to report previous PA levels for the participants, but did not include a control 
group and compared VO2max between youth with T1D and T2D. Faulkner (2010) employed the 
Physical Activity Recall, which obtains information on participants’ recent PA participation for 
the previous 7 days. Using a 7-day recall towards assessing exercise history is insufficient to 
understand a participants long-term non-exercise plus exercise physical activity habits and 
properly categorize their physical plus physiological fitness levels. The athletes with T1D who 
participated in the present investigation were matched for physical plus physiological fitness 
levels, with the ND recruited from the same hockey team. Therefore, the PA levels did not differ 
between pairs in terms of frequency and intensity of training and game schedule. This may be 
one reason why a difference in VO2max was not observed between the two groups.  
 To avoid some of the inherent weaknesses in the previous investigations, the present 
investigation employed the following:  
1) Matched controls for age, sex, height, body mass, and non-exercise plus exercise PA 
levels. We recruited the participants from the same ice-hockey team to ensure no 
difference in habitual exercise. This was essential, as if it was found that the participants 
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with T1D had lower VO2max, VO2 and HR responses it would undoubtedly be diabetes 
related. Previous investigators may not have matched for physical plus physiological 
fitness levels, and consequently, would not have been founded on a select, athletic 
population. 
2) Directly measured VO2 and HR and documented the responses during the simulation 
hockey game (HITT) to identify any abnormalities in the rate of the response of 
individuals with T1D at any time point during exercise. 
3) Used elite athletic participants who already possessed a high aerobic capacity and were 
familiar with strenuous, high-intensity exercise. Therefore, fatigue or exercise 
incapability due to deconditioning or low exercise tolerance possibly confounding the 
results was avoided. 
4) Carefully considered the protocol design, which simulated a 60 minute ice-hockey game. 
Recording HR during an on-ice game allowed for a more accurate/comprehensive idea 
of the intensity and energy demand required by the athletes during a real-life game. 
This approach enabled us to design a high-intensity intermittent laboratory protocol 
incorporating the appropriate frequency, intensity and duration of hockey shifts (sprints 
vs. active recovery) and bench times. One limitation of the laboratory protocol was that 
even though the participants were instructed to approach the simulation hockey game 
as they would a real-life ice-hockey game, the protocol could not simulate the same 
motivation and adrenaline that the individuals would experience during an actual on-ice 
game. 
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Another relevant finding reported by Veves et al. (1997) was that the VO2max of the 
NDE group was lower (42.0 ± 11.6 mL·kg-1·min-1) compared with the CE and DE groups, and 
similar to those of the sedentary CS (38.7 ± 6.0 mL·kg-1·min-1) and DS (36.7 ± 9.6 mL·kg-1·min-1) 
groups. These findings indicate that with additional diabetic related complications exercise 
capacity is decreased. While this is true, many studies have proven that PA and exercise can 
reduce diabetes related comorbidities and improve quality of life (Chu et al., 2011; Komatsu et 
al., 2005; Mosher et al., 1998; Rowland et al., 1992; Sideraviciute et al., 2006; Veves et al., 
1997; Wasserman & Zinman, 1994; Zinker, 1999). In addition, studies that have investigated the 
effects of exercise programs on the VO2max of children and adolescents with T1D, have 
reported significant increases in aerobic fitness (Campaigne, et al., 1984; Mosher et al., 1998). 
Some studies have reported increases in peak aerobic fitness (VO2peak) as much as 27% in 
individuals with T1D (Chimen et al., 2012), which indicates that individuals with T1D can 
improve cardiorespiratory function similar to ND with exercise training. These findings reaffirm 
the significance of PA and exercise as a beneficial component for long-term physical plus 
physiological fitness and health for individuals with T1D.  
This is the first study to characterize the VO2 and HR responses in youths with 
uncomplicated T1D in response to a HITT protocol. We chose a simulated hockey game because 
of the sport’s unique high-intensity and intermittent nature and its popularity among Canadian 
youth. The high-intensity bursts of activity, the prolonged duration of a full-length game, and 
the need for rapid recovery between shifts demands strength, power, and high anaerobic and 
aerobic fitness. Regensteiner et al. (1998), Brandenburg et al. (1999), Bauer et al. (2007), and 
Ananey et al. (2011) are the only authors who have published data on VO2 and HR kinetics of a 
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diabetic population in response to constant-load exercise. These studies involved measuring 
the VO2 and HR kinetics of persons with T2D during constant-load exercise above and below the 
lactate threshold. Regensteiner et al. (1998) characterized the VO2 and HR kinetic response in 
premenopausal women with T2D during constant-load exercise and found that they had a 
reduced response compared to both their lean and overweight controls. The authors concluded 
that the impaired cardiac response observed at the onset of exercise compromised oxygen 
delivery attributing to the limited response rate, but Regensteiner et al. (1998) did not exclude 
the possibility of an additional defect in skeletal muscle oxygen diffusion or mitochondrial 
oxygen utilization. Brandenburg et al. (1999), in response to Regensteiner’s findings, examined 
if VO2max and VO2 kinetics would improve with exercise training in untrained premenopausal 
women with T2D before and after 3 months of supervised training. Before training the women 
with T2D had the lowest VO2max and slowest VO2 kinetics. Brandenburg et al. (1999) found 
that after the exercise program the women with T2D benefited more from the exercise training 
than the controls. Ananey et al. (2011) investigated whether an abnormal cardiac output 
response was related to VO2 kinetics in middle-aged women with uncomplicated T2D. All the 
participants were sedentary (< 1 hr/wk of moderate-intensity exercise) for at least 3 months 
before the study commenced, which was determined via the Low-Level PA Recall 
questionnaire. The results showed that the VO2peak was significantly lower in the participants 
with T2D compared with both their overweight and lean controls. The participants with T2D 
had a slowed dynamic response in VO2 during light and moderate intensity exercise, but this 
occurred in the absence of a reduced cardiac output response during exercise; HR kinetics had a 
similar response. To explain the slowed VO2 kinetics observed in the T2D group, the 
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investigators proposed that it was attributable to blood flow and the arteriovenous oxygen 
difference (a-v O2). Blood flow could be limited by poor cardiac output and/or impaired 
vasodilation, whereas a-v O2 reflects the interaction between blood flow and myocyte VO2. 
Consequently, due to the slow rise in oxygen consumption by the contracting muscles, there is 
a slower increase in a-v O2, subsequently impairing the VO2 kinetic response.  
The present investigation was the first to examine the dynamic response of VO2 and HR 
during HITT, specifically a simulation hockey game. Since the exponential equations for 
calculating kinetics cannot be applied to HITT, we characterized the VO2 and HR response in 
athletic youths with and without T1D by calculating the average nadir, mean, and average peak 
%VO2max and %HRmax for every play shift and bench intervals. Some differences were 
observed between the 3 periods in both the T1D and ND groups. Looking at Figures 11 and 12, 
the differences between the play shifts and bench intervals appear to be random and 
inconsistent across periods 1, 2 and 3. Since the differences were observed in both groups, it is 
doubtful that the response is attributed to diabetes related exercise intolerance. Therefore, the 
differences in the average nadir and average peak %VO2max and %HRmax values are most 
likely attributed to the athletes’ self-selected pacing during the simulation hockey game.  
The T1D group had similar average nadir and average peak %VO2max and %HRmax 
responses in comparison with the ND group throughout the simulation hockey game; no 
differences between the responses were evident. This is a select population given that they 
were highly active individuals with well-controlled glycemia, and did not possess any diabetes 
related comorbidities. It seems that within this elite-athletic population, the VO2 response is 
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not hindered. During the simulation hockey game, the individuals with T1D were able to reach 
similar peaks in %VO2max and %HRmax during the exercise play shifts (Figures 9 and 10) as the 
ND participants. This suggests that individuals with T1D are not physiologically limited by 
diabetes during HITT and are able to uptake, deliver, and utilize oxygen efficiently. The 
paralleled HR response between the groups with and without T1D gives no indication of 
cardiovascular impairment during this type of exercise. These findings also suggest, there is no 
sign of diabetes related fatigue, or reduced aerobic endurance due to abnormalities in the 
function and rate of oxygen transportation or diffusion. On the basis of the Fick equation for 
VO2, VO2 is influenced by a combination of cardiovascular and peripheral factors. In the absence 
of physiological data, a limitation of the current study, the effect of T1D on the VO2 and HR 
response to HITT is difficult to explain. Understanding the physiological mechanisms that 
control the dynamic response of VO2 in T1D is important, as a reduction in this response may be 
linked to increased fatigue during exercise.  
In addition to understanding the physiological significance of the VO2 response in 
individuals with T1D, it is also essential to recognize the clinical significance (Brandenburg et al., 
1999). If youth with T1D are discouraged from participating in sport and exercise due to lack of 
knowledge and apprehension, they are more likely to avoid PA leading to low exercise 
tolerance. Sequentially this may contribute to an individual’s perception of their ability to 
initiate or to perform exercise and non-exercise PA as being more difficult (Brandenburg et al., 
1999). Ultimately this could dissuade individuals from adopting a more physically active 
lifestyle. Increasing the awareness on the positive effects of exercise on T1D and improving the 
initial experience to exercise are necessary to encourage participation and reduce the 
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unwillingness to engage in PA and exercise. Understanding the magnitude and causes of any 
exercise impairment is crucial to improving performance and preventing increasing disability in 
this population. 
The focus of VO2 and HR responses to HITT in persons with T1D is relatively new, and 
greatly revolves around the glucoregulatory response (Bussau, Ferreira, Jones, & Fournier, 
2006; Bussau, Ferreira, Jones, & Fournier, 2007; Guelfi et al., 2005; Guelfi et al., 2007; 
Robertson et al., 2009). These investigations have consistently shown that HITT is well tolerated 
by individuals with uncomplicated T1D. Guelfi et al. (2007) revealed that males and females 
with T1D (22.6 ± 5.7 years) performed a superior amount of total work during HITT compared 
with continuous moderate-intensity exercise. This was reflected by the greater response of VO2 
and HR during HITT; the average rate of VO2 consumption during HITT corresponded to 55% of 
VO2peak in comparison with 40% during moderate-intensity exercise. In the current study the 
participants with T1D frequently reached 60-100% of their VO2max and HRmax during the 
simulation hockey game protocol. This shows that there is a significant amount of aerobic work 
being done during HITT and that this type of exercise is not solely reliant on the anaerobic 
system.  
In the same investigation conducted by Guelfi et al. (2007), the participants acted as 
their own controls. Guelfi et al. (2007) created a 30-minute HITT protocol (cycling at 40% 
VO2peak, interspersed with 4-second maximal sprint efforts performed every 2 minutes) based 
on other researchers investigations on time-motion analyses of various intermittent sports 
(soccer, hockey, gaelic football) and spontaneous play in children. The present investigation is 
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the first to show T1D in a full-length simulation hockey game protocol based on HR response 
collected during an on-ice hockey game. Building on the previous research regarding T1D and 
HITT, this study now shows that the VO2 and HR response of athletic youth with T1D are not 
limited by diabetes while performing HITT. Like their healthy counterparts, they have the 
aerobic fitness level to perform long durations of intermittent high-intensity activity. This is very 
important, as it proves that youth with uncomplicated T1D have the ability to be just as 
competitive in sports as healthy ND individuals. 
The results of the current investigation suggest that similar training status and exercise 
histories play a great role in the determination of aerobic fitness in youth with uncomplicated 
T1D. It is concluded that athletic adolescents with T1D achieve similar VO2max and HRmax 
values, plus exhibit similar VO2 and HR responses during a simulated hockey game when 
compared to their ND counterparts. The results indicate that adolescents with uncomplicated 
T1D can participate in sports, exercise and non-exercise PA at the same level as their ND 
counterparts, and not be limited by diabetes. Along with previous studies, this investigation 
reaffirms the benefits of being an active individual with T1D; as it increases physical and 
physiological fitness, and may prevent further disability, and ultimately influences quality of life. 
This investigation offers a more optimistic view as it suggests that diabetes itself does not affect 
the exercising capacity in trained individuals, and underscores that athletic youth with 
uncomplicated T1D have the exercise capacity and potential to participate safely in competitive 
sport, exercise and non-exercise PA.  
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2.4  LIMITATIONS 
Currently there are no investigations that have focused on the VO2 and HR response of 
youth with T1D during HITT protocol. This is the first study of its kind and consequently it is 
difficult to draw comparisons with previous investigations and findings as there is no access to 
detailed literature in the area. As well, research focused in the area of T1D, HITT and VO2 
kinetics is still novel. It is necessary to establish a method that investigators can employ for 
analysing VO2 kinetics during HITT. This would be extremely advantageous for future research 
in intermittent PA and exercise, not only in persons with T1D, but also in persons with various 
chronic diseases and conditions. 
The participants involved in the present investigation were recruited from a select 
population. The individuals represented a male and female population ranging from 13-17 
years with a high aerobic fitness levels (mean VO2max = 55.6 mL·kg
-1·min-1), who all competed 
in high level competitive hockey. Therefore, generalizations to other active T1D populations 
may not be appropriate. It would be beneficial to conduct the study with a larger sample size, 
as well as include an equal number of males and females in the sample to compare any possible 
sex-related differences. It also would be advantageous to include a sedentary control and 
sedentary diabetic group for a more comprehensive understanding of the VO2 and HR response 
during HITT.  
Additionally, the small number of study participants in this study may not allow for 
generalizations to be made to all individuals with T1D. For instance, these findings cannot be 
generalized to individuals with T1D with poor glycemic control and/or diabetes related 
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comorbidities. Not only would these individuals possess a lower exercise tolerance, but the 
nature of HITT may not be well tolerated by individuals with complicated T1D. It has been 
recommended that individuals with diabetes related conditions, like proliferative retinopathy or 
nephropathy, avoid PA that can result in high arterial blood pressure such as lifting heavy 
weights and performing high intensity sprints (Robertson et al., 2009). A separate study looking 
at individuals with T1D with poor glycemic control and/or diabetes related comorbidities would 
be meaningful to identify the types of exercise that would be well tolerated and beneficial to 
their health. 
A final limitation is that all performance measurements were conducted in a laboratory 
setting, and as such, generalizations to on-ice game situations may be limited. Despite 
employing the Cosmed Fitmate (a reliable and accurate VO2 system) to measure and record VO2 
and HR, the device could have predicted some erroneous values. As well, due to failure of the 
Fitmate system, some data were lost. There were incidences where the Fitmate started 
recording the data late, stopped recording before the protocol was completed, or failed to 
record the data entirely. As a result, differences in the VO2 and HR responses may have been 
missed. It would have been ideal for the participants whose data were lost to be scheduled to 
perform the laboratory protocol on a subsequent day so that their data could have been 
included in the analysis. 
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2.5  IMPLICATIONS 
Exploring this relatively novel area of research has enhanced the understanding of the 
VO2 and HR responses during HITT in highly active persons with uncomplicated T1D. The 
behaviour of the VO2 and HR response have been characterized in the present investigation and 
have demonstrated that active youth with uncomplicated T1D and well controlled glycemia 
have a similar VO2 and HR response to healthy active ND youths. The results of this study 
provide individuals with T1D, parents, and clinicians with T1D with more insight regarding the 
cardiovascular response and the limitations associated with PA participation. With an in-depth, 
comprehensive understanding of persons with T1D and their response to various types of PA 
and exercise, perceived barriers like fear or apprehension can be assuaged, thereby 
encouraging youth with T1D to increase their participation in both recreational and high-level 
competitive sports. It is not unheard of to see great athletes with T1D making a successful 
career for themselves in sport like: Jay Cutler, quarterback for the NFL’s Chicago Bears, Brandon 
Morrow and Dustin McGowan for MLB’s Toronto Blue Jays, and Bobby Clarke, Captain of the 
NHL’s Philadelphia Flyers. Clarke had a 15-year career with many accomplishments, playing in 
over 1,000 regular season games, scoring 358 goals, and winning 2 Stanley cups (Macleod, 
2015). Clarke has been an inspiration to many young hockey players with T1D, specifically Max 
Domi, who is an up-incoming NHL star (Macleod, 2015). Domi was a first-round draft pick in 
2014, is a top prospect for the NHL’s Arizona Coyotes, and participated in the World Junior 
Championship on Team Canada, finishing as the tournaments best forward. It is important to 
have respected figures paving the way for individuals with T1D in highly competitive and elite 
domains.  
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Further research is essential within this subject area to amalgamate highly accurate, 
evidence-based guidelines for persons with complicated and uncomplicated T1D who engage in 
exercise and sports characterized by intermittent high-intensity activity. It would be valuable to 
investigate the VO2 and HR response to HITT in a population of middle age athletes with 
complicated and uncomplicated T1D. As well, conducting a longitudinal study following highly 
active youth with T1D would provide insight into understanding the possible repercussions of 
age and long-term T1D on the physical plus physiological fitness levels in these individuals. The 
more knowledge acquired on athletes with T1D and their response to exercise, the better 
coaches and exercise trainers can assist and properly train athletic youth with T1D. With an 
increase in available information, young athletes with T1D will no longer have to be 
apprehensive of exercise and non-exercise PA, showing them that with the proper regimen, 
discipline and care, their bodies can perform at the same level as their normal healthy 
counterparts. Ultimately research in this domain could assist in attenuating the apprehension 
associated with T1D and exercise plus non-exercise PA, and may foster greater participation of 
youth with T1D in competitive sport. Athletic figures like Clarke and Domi prove that individuals 
with T1D are not only able to live normal lives, but may also live extraordinary ones. 
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APPENDIX C: CONSENT FORMS 
Minor Assent Form 
 
Study Name: Assessing the impact of intermittent high-intensity exercise on subsequent glucose management and 
autonomic function in elite-level youth athletes with type 1 diabetes 
 
Researchers: Dr. Michael Riddell, Dr. Veronica Jamnik 
Lisa Miadovnik, MSc Candidate, Kinesiology & Health Science, York University 
   
Purpose of the Research:This will be the first study completed and published on type 1 diabetic hockey players. 
Because of the unique glycemic response reported in hockey players, we want to see how this type of exercise 
impacts later glucose management. We also want to see how hockey-type exercise impacts overnight autonomic 
function. Autonomic function refers to how the nervous system functions and can be measured by looking at heart 
rate variability. A Holter monitor is used to assess heart rate variability, which is basically the variation in the time 
interval between heartbeats. Since a healthy nervous system constantly changes how it stimulates the heart, a healthy 
person will have high heart rate variability. Our overall goal is to determine the effects that hockey and hockey-type 
exercise have on your blood sugar management and heart rate variability afterwards. We also want to see if blood 
sugar levels impact heart rate variability. This research will be presented to graduate students and professors at a 
seminar held at York University. We also aim to have it published in an academic journal, and presented at various 
professional conferences on diabetes.  
 
What You Will Be Asked to Do in the Research: This study will require 2 trips to the Human Performance 
Laboratory at York University. All participants will complete an initial fitness assessment in the laboratory which 
will take roughly 1.5 hours. This assessment will include measurement of height, weight, skinfolds/body fat, and 2 
maximal exertion cardiorespiratory tests. On this visit, each participant will be required to complete a 30-second 
Wingate anaerobic cycling test, and a 15-20 minute aerobic (VO2 max) test performed on a motorized treadmill. 
 
Participants will also be required to visit the lab on a 2
nd
 occasion which will last 2.5-3 hours. During this visit, the 
participants will complete an exercise protocol on a cycle ergometer which mimics the work done by the legs during 
a hockey game. This protocol will involve 45 minutes of intermittent cycling, which will take place over a 60 minute 
time frame (to simulate a game). Participants will wear a polar heart rate strap, and a Fitmate
TM
 VO2 device which 
will continuously measure the amount of oxygen you’re using – or how hard you’re working. Following the 
completion of this protocol, all equipment will be removed and a Holter Monitor
 TM
 will be placed on the participant. 
This monitor will be worn for 30 minutes in exercise recovery, while lying down in a dark, quiet room. 
 
The Holter Monitor
 TM
 is a small electronic device, worn on the hip. Connected to it are 5 wires with gel pads that 
are stuck to the front of the chest cavity. These gel pads pick up electrical activity of the heart, and transmit the 
information to the monitor, where the information is recorded. This monitor is to be worn on 3 occasions, from 
12:00 AM or earlier, until 6:00 AM or later. One occasion will be after completing the lab exercise protocol as 
mentioned above. A second occasion will be after a hockey game, and a third occasion will be after a low-activity 
day. Individuals will be asked to record the activities they partake in on each of these 3 days. It is important that 
minimal physical activity is performed on the low-activity day. 
 
All of the above requirements apply to both participants with diabetes, and their control (non-diabetic) 
participants. All procedures listed above are non-invasive. 
 
Participants with diabetes will have the additional requirement of wearing a Medtronic iPro2, blinded continuous 
glucose monitor (CGM), for the 3 days when they assess their nocturnal heart rate variability. Scheduling will be 
designed so that all 3 data collection nights (ie after the hockey game, after the lab exercise protocol, and after the 
low-activity day) occur within a 5-day span. While wearing the CGM, participants will also be asked to manually 
check their blood sugar using their own glucose monitoring device at least once every 9 hours, and record all 
carbohydrate consumption and insulin administrations on the provided sheets. 
 
Risks and Discomforts: Because this strenuous exercise is known to induce hyperglycemia during exercise, 
participants may suffer post-exercise hypoglycemia afterward. Participants will receive coaching on how to reduce 
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the incidence of hypoglycemia by exercise specialists such as Dr. Riddell - for example, reduce onboard insulin to 
zero during exercise, restrict insulin after exercise, and monitor blood glucose levels closely after exercise so that if 
levels start to drop, glucose can be consumed. Participants are also exposed to the typical risk of injury that is 
associated with exercise, including fatigue, lightheadedness, loss of consciousness, abnormal blood pressure, chest 
discomfort, leg gramps, nausea, and in rare cases, heart rhythm disturbances or heart attacks. Because all 
participants are elite athletes who are accustomed to intense exericse, the likelihood of experiencing the above side 
effects are quite small. Additionally, exercise will be supervised by qualified professionals to limit the risks to the 
participants, and a consent form will be read and signed by the dependent's parent or guardian prior to initiating the 
study. PAR-Q+ and if necessary, ePAR-medX evaluations will also be completed prior to exercise to insure 
participants are all eligible to partake in exercise, and understand the associated risks.  
 
Benefits of the Research and Benefits to You: You will have the opportunity to participate in unique fitness 
testing procedures that are common to many elite and national-level athletes. You will also have access to your 
CGM data upon study completion, to observe the impact of hockey on your blood sugar management.  
 
Voluntary Participation: Your participation in the study is completely voluntary and you may choose to stop 
participating at any time. Your decision not to volunteer will not influence the nature of the relationship you may 
have with the researchers or study staff, or the nature of your relationship with York University either now, or in the 
future. 
 
Withdrawal from the Study:  You can stop participating in the study at any time, for any reason, if you so decide. 
Your decision to stop participating, or to refuse to answer particular questions, will not affect your relationship with 
the researchers, York University, or any other group associated with this project. If you choose to withdraw from the 
study, all associated data collected will be immediately destroyed if you choose. 
 
Confidentiality: All information you supply during the research will be held in confidence and unless you 
specifically indicate your consent, your name will not appear in any report or publication of the research.  Data will 
be collected via hand-written notes, and converted into electronic documents where possible. All collected 
information will be coded to preserve your anonymity. Your data will be safely stored in a password-protected 
computer in a locked facility and only research staff will have access to this information. Confidentiality will be 
provided to the fullest extent possible by law. Collected data will be kept for a maximum of 5 years, after which 
time it will be destroyed. 
 
Questions About the Research?  If you have questions about the research in general or about your role in the 
study, please feel free to contact Lisa Miadovnik or the Graduate Supervisor - Dr. Michael Riddell either by 
telephone (listed above) or by e-mail. This research has received approval by the Human Participants Review Sub-
Committee, York University’s Ethics Review Board and conforms to the standards of the Canadian Tri-Council 
Research Ethics guidelines.  If you have any questions about this process or about your rights as a participant in the 
study, please contact the Sr. Manager & Policy Advisor for the Office of Research Ethics, 5
th
 Floor, York Research 
Tower, York University. 
 
Legal Rights and Signatures: 
I _____________________, consent to participate in “Assessing the impact of intermittent high-intensity exercise 
on subsequent glucose management and autonomic function in elite-level youth with type 1 diabetes” conducted by 
Lisa Miadovnik, Supervised by Dr. Michael Riddell & Dr. Veronica Jamnik.  I have understood the nature of this 
project and wish to participate.  I am not waiving any of my legal rights by signing this form.  My signature below 
indicates my consent. 
 
Signature     Date        
Participant 
 
Signature     Date        
Principal Investigator 
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Parental Consent Form 
 
Study Name: Assessing the impact of intermittent high-intensity exercise on subsequent glucose management and 
autonomic function in elite-level youth athletes with type 1 diabetes 
 
Researchers: Dr. Michael Riddell, Dr. Veronica Jamnik 
Lisa Miadovnik, MSc Candidate, Kinesiology & Health Science, York University,  
   
Purpose of the Research: This research aims to be the first-ever study completed and published on type 1 diabetic 
hockey players. Given the unique glycemic response reported in hockey players, we aim to assess the impact of this 
type of exercise on subsequent glucose management. We also aim to assess the acute effects of hockey-type exercise 
on nocturnal autonomic function. Autonomic function refers to how the nervous system functions and can be 
measured by looking at heart rate variability. A Holter monitor is used to assess heart rate variability, which is 
basically the variation in the time interval between heartbeats. Since a healthy nervous system constantly changes 
how it stimulates the heart, a healthy person will have high heart rate variability. Our overall purpose is to determine 
the nocturnal effects of hockey and hockey-type exercise on blood sugar management and heart rate variability, and 
to determine whether the two markers are correlated. This research will be presented to peers at a graduate seminar 
held at York University. We also aim to have it published in a scholarly journal, and presented at various 
professional conferences on diabetes. All participants will remain anonymous. 
 
What You Will Be Asked to Do in the Research: This study will require 2 trips to the Human Performance 
Laboratory at York University. All participants will require an initial fitness assessment in the laboratory which will 
take roughly 1.5 hours. This assessment will include measurement of height, weight, skinfolds/body fat, and 2 
maximal exertion cardiorespiratory tests. On this visit, each participant will be required to complete a 30-second 
Wingate anaerobic cycling test, and a 15-20 minute aerobic (VO2 max) test performed on a motorized treadmill. 
 
Participants will also be required to visit the lab on a 2
nd
 occasion which will last 2.5-3 hours. During this visit, the 
participants will complete an exercise protocol on a cycle ergometer which mimics the work done by the legs during 
a hockey game. This protocol will involve 45 minutes of intermittent cycling, which will take place over a 60 minute 
time frame (to simulate a game). Participants will be fitted with a polar heart rate strap, and a Fitmate
TM
 VO2 device 
which will continually assess the volume of oxygen utilized by the exercising individual. Following the completion 
of this protocol, individuals will be asked to lay down for 30 minutes to assess heart rate variability in recovery. This 
monitor will be worn for 30 minutes in exercise recovery, while lying down in a dark, quiet room. 
 
The Holter Monitor
 TM
 is a small electronic device, worn on the hip. Connected to it are 5 wires with gel pads that 
are stuck to the front of the chest cavity. These gel pads pick up electrical activity of the heart, and transmit the 
information to the monitor, where the information is recorded. This monitor is to be worn on 3 occasions, from 
12:00 AM or earlier, until 6:00 AM or later. One occasion will be after completing the lab exercise protocol as 
mentioned above. A second occasion will be after a hockey game, and a third occasion will be after a low-activity 
day. Individuals will be asked to record the activities they partake in, on each of these 3 days. It is important that 
minimal physical activity is performed on the low-activity day. 
 
All of the above requirements apply to both participants with diabetes, and their control (non-diabetic) 
participants. All procedures listed above are non-invasive. 
 
Participants with diabetes will have the additional requirement of wearing a Medtronic iPro2, blinded continuous 
glucose monitor (CGM), for the 3 days when they assess their nocturnal heart rate variability. As such, scheduling 
will be designed such that all 3 data collection nights (ie after the hockey game, after the lab exercise protocol, and 
after the low-activity day) occur within a 5-day span. While wearing the CGM, participants will also be asked to 
manually check their blood sugar using their own glucose monitoring device at least once every 9 hours, and record 
all carbohydrate consumption and insulin administrations on the provided sheets. 
 
Risks and Discomforts: Because exercise of this intensity is known to induce hyperglycemia during exercise, 
participants may suffer post-exercise hypoglycemia afterward. Participants will receive coaching on how to reduce 
the incidence of hypoglycemia by exercise specialists such as Dr. Riddell - for example, reduce onboard insulin to 
zero during exercise, restrict insulin after exercise, and monitor blood glucose levels closely after exercise so that if 
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levels start to drop, glucose can be consumed. Participants are also exposed to the typical risk of injury that is 
associated with exercise, including fatigue, episodes of transient lightheadedness, loss of consciousness, abnormal 
blood pressure, chest discomfort, leg gramps, nausea, and in rare cases, heart rhythm disturbances or heart attacks. 
Because all participants are elite athletes who are accustomed to intense exericse, the likelihood of experiencing the 
above side effects are quite small. Additionally, exercise will be supervised by qualified professionals to reduce 
potential risks to the participants, and a consent form will be read and signed by the dependent's parent or guardian 
prior to initiating the study. PAR-Q+ and if necessary, ePAR-medX evaluations will also be completed prior to 
exercise to insure participants are all eligible to partake in exercise, and understand the associated risks. 
 
Benefits of the Research and Benefits to You: Participants will have the opportunity to experience unique fitness 
testing procedures that are common to many elite and national-level athletes. They will also have access to their 
CGM data upon study completion, to observe the impact of hockey on their blood sugar management. This 
information will be available as a result of their participation in this study. 
 
Voluntary Participation: Participation in the study is completely voluntary and individuals may choose to stop 
participating at any time.  The decision not to volunteer will not influence the nature of the ongoing relationship you 
may have with the researchers or study staff, or the nature of your relationship with York University either now, or 
in the future. 
 
Withdrawal from the Study:  You or your dependent can stop participating in the study at any time, for any 
reason, if you so decide. Your decision to stop participating, or to refuse to answer particular questions, will not 
affect your relationship with the researchers, York University, or any other group associated with this project. In the 
event you withdraw from the study, all associated data collected will be immediately destroyed if you choose. 
 
Confidentiality: All information supplied during the research will be held in confidence and unless consent is  
specifically indicated, names will not appear in any report or publication of the research.  Data will be collected via 
hand-written notes, and converted into electronic documents where possible. All collected information will be coded 
to preserve your anonymity. Data will be safely stored in a password-protected computer in a locked facility and 
only research staff will have access to this information. Confidentiality will be provided to the fullest extent possible 
by law. Collected data will be kept for a maximum of 5 years, after which time it will be destroyed. 
 
Questions About the Research?  If you have questions about the research in general or about your role in the 
study, please feel free to contact Lisa Miadovnik or the Graduate Supervisor - Dr. Michael Riddell either by 
telephone (listed above) or by e-mail. This research has received approval by the Human Participants Review Sub-
Committee, York University’s Ethics Review Board and conforms to the standards of the Canadian Tri-Council 
Research Ethics guidelines.  If you have any questions about this process, or about your rights as a participant in the 
study, please contact the Sr. Manager & Policy Advisor for the Office of Research Ethics, 5
th
 Floor, York Research 
Tower, York University. 
Legal Rights and Signatures: 
 
I _____________________, provide my consent for my dependent to participate in “Assessing the impact of 
intermittent high-intensity exercise on subsequent glucose management and autonomic function in elite-level youth 
with type 1 diabetes” conducted by Lisa Miadovnik, Supervised by Dr. Michael Riddell & Dr. Veronica Jamnik.  I 
have understood the nature of this project and wish my dependent to participate.  I am not waiving any of my legal 
rights by signing this form.  My signature below indicates my consent. 
 
Signature     Date        
Participant 
 
 
Signature     Date        
Principal Investigator 
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Informed Consent Form 
Study Name: Assessing the impact of intermittent high-intensity exercise on subsequent glucose management and 
autonomic function in elite-level youth athletes with type 1 diabetes 
 
Researchers: Dr. Michael Riddell, Dr. Veronica Jamnik 
Lisa Miadovnik, MSc Candidate, Kinesiology & Health Science, York University 
   
Purpose of the Research: This research aims to be the first-ever study completed and published on type 1 diabetic 
hockey players. Given the unique glycemic response reported in hockey players, we aim to assess the impact of this 
type of exercise on subsequent glucose management. We also aim to assess the acute effects of hockey-type exercise 
on nocturnal autonomic function. Autonomic function refers to how the nervous system functions and can be 
measured by looking at heart rate variability. A Holter monitor is used to assess heart rate variability, which is 
basically the variation in the time interval between heartbeats. Since a healthy nervous system constantly changes 
how it stimulates the heart, a healthy person will have high heart rate variability. Our overall purpose is to determine 
the nocturnal effects of hockey and hockey-type exercise on blood sugar management and heart rate variability, and 
to determine whether the two markers are correlated. This research will be presented to peers at a graduate seminar 
held at York University. We also aim to have it published in a scholarly journal, and presented at various 
professional conferences on diabetes. All participants will remain anonymous. 
 
What You Will Be Asked to Do in the Research: This study will require 2 trips to the Human Performance 
Laboratory at York University. All participants will require an initial fitness assessment in the laboratory which will 
take roughly 1.5 hours. This assessment will include measurement of height, weight, skinfolds/body fat, and 2 
maximal exertion cardiorespiratory tests. On this visit, each participant will be required to complete a 30-second 
Wingate anaerobic cycling test, and a 15-20 minute aerobic (VO2 max) test performed on a motorized treadmill. 
 
Participants will also be required to visit the lab on a 2
nd
 occasion which will last 2.5-3 hours. During this visit, the 
participants will complete an exercise protocol on a cycle ergometer which mimics the work done by the legs during 
a hockey game. This protocol will involve 45 minutes of intermittent cycling, which will take place over a 60 minute 
time frame (to simulate a game). Participants will be fitted with a polar heart rate strap, and a Fitmate
TM
 VO2 device 
which will continually assess the volume of oxygen utilized by the exercising individual. Following the completion 
of this protocol, individuals will be asked to lay down for 30 minutes to assess heart rate variability in recovery. This 
monitor will be worn for 30 minutes in exercise recovery, while lying down in a dark, quiet room. 
 
The Holter Monitor
 TM
 is a small electronic device, worn on the hip. Connected to it are 5 wires with gel pads that 
are stuck to the front of the chest cavity. These gel pads pick up electrical activity of the heart, and transmit the 
information to the monitor, where the information is recorded. This monitor is to be worn on 3 occasions, from 
12:00 AM or earlier, until 6:00 AM or later. One occasion will be after completing the lab exercise protocol as 
mentioned above. A second occasion will be after a hockey game, and a third occasion will be after a low-activity 
day. Individuals will be asked to record the activities they partake in, on each of these 3 days. It is important that 
minimal physical activity is performed on the low-activity day. 
 
All of the above requirements apply to both participants with diabetes, and their control (non-diabetic) 
participants. All procedures listed above are non-invasive. 
 
Participants with diabetes will have the additional requirement of wearing a Medtronic iPro2, blinded continuous 
glucose monitor (CGM), for the 3 days when they assess their nocturnal heart rate variability. As such, scheduling 
will be designed such that all 3 data collection nights (ie after the hockey game, after the lab exercise protocol, and 
after the low-activity day) occur within a 5-day span. While wearing the CGM, participants will also be asked to 
manually check their blood sugar using their own glucose monitoring device at least once every 9 hours, and record 
all carbohydrate consumption and insulin administrations on the provided sheets. 
 
Risks and Discomforts: Because exercise of this intensity is known to induce hyperglycemia during exercise, 
participants may suffer post-exercise hypoglycemia afterward. Participants will receive coaching on how to reduce 
the incidence of hypoglycemia by exercise specialists such as Dr. Riddell - for example, reduce onboard insulin to 
zero during exercise, restrict insulin after exercise, and monitor blood glucose levels closely after exercise so that if 
levels start to drop, glucose can be consumed. Participants are also exposed to the typical risk of injury that is 
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associated with exercise, including fatigue, episodes of transient lightheadedness, loss of consciousness, abnormal 
blood pressure, chest discomfort, leg gramps, nausea, and in rare cases, heart rhythm disturbances or heart attacks. 
Because all participants are elite athletes who are accustomed to intense exericse, the likelihood of experiencing the 
above side effects are quite small. Additionally, exercise will be supervised by qualified professionals to reduce 
potential risks to the participants, and a consent form will be read and signed by the dependent's parent or guardian 
prior to initiating the study. PAR-Q+ and if necessary, ePAR-medX evaluations will also be completed prior to 
exercise to insure participants are all eligible to partake in exercise, and understand the associated risks. 
 
Benefits of the Research and Benefits to You: Participants will have the opportunity to experience unique fitness 
testing procedures that are common to many elite and national-level athletes. They will also have access to their 
CGM data upon study completion, to observe the impact of hockey on their blood sugar management. This 
information will be available as a result of their participation in this study. 
 
Voluntary Participation: Participation in the study is completely voluntary and individuals may choose to stop 
participating at any time.  The decision not to volunteer will not influence the nature of the ongoing relationship you 
may have with the researchers or study staff, or the nature of your relationship with York University either now, or 
in the future. 
 
Withdrawal from the Study:  You can stop participating in the study at any time, for any reason, if you so decide. 
Your decision to stop participating, or to refuse to answer particular questions, will not affect your relationship with 
the researchers, York University, or any other group associated with this project. In the event you withdraw from the 
study, all associated data collected will be immediately destroyed if you choose. 
 
Confidentiality: All information you supply during the research will be held in confidence and unless you 
specifically indicate your consent, your name will not appear in any report or publication of the research.  Data will 
be collected via hand-written notes, and converted into electronic documents where possible. All collected 
information will be coded to preserve your anonymity. Your data will be safely stored in a password-protected 
computer in a locked facility and only research staff will have access to this information. Confidentiality will be 
provided to the fullest extent possible by law. Collected data will be kept for a maximum of 5 years, after which 
time it will be destroyed. 
 
Questions About the Research?  If you have questions about the research in general or about your role in the 
study, please feel free to contact Lisa Miadovnik or the Graduate Supervisor - Dr. Michael Riddell either by 
telephone (listed above) or by e-mail. This research has received approval by the Human Participants Review Sub-
Committee, York University’s Ethics Review Board and conforms to the standards of the Canadian Tri-Council 
Research Ethics guidelines.  If you have any questions about this process, or about your rights as a participant in the 
study, please contact the Sr. Manager & Policy Advisor for the Office of Research Ethics, 5
th
 Floor, York Research 
Tower, York University. 
 
Legal Rights and Signatures: 
I _____________________, provide my consent to participate in “Assessing the impact of intermittent high-
intensity exercise on subsequent glucose management and autonomic function in elite-level youth with type 1 
diabetes” conducted by Lisa Miadovnik, Supervised by Dr. Michael Riddell & Dr. Veronica Jamnik.  I have 
understood the nature of this project and wish to participate.  I am not waiving any of my legal rights by signing this 
form.  My signature below indicates my consent. 
 
Signature     Date        
Participant 
 
Signature     Date        
Principal Investigator 
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APPENDIX D: Simulation Hockey Game Protocol (Miadovnik, 2013) 
Name:  
Date:             
Resistance:     Pre-Weight:   Post-Weight:   Pre-BG: 
Shift Cosmed 
Time 
On Ice Play – Whistle – Play 
 
Off Ice/ 
Bench 
BG 
Check 
1  0:00 20 –20– 40 1:20  
Period 1  RPM/HR/VO2    
Period 2  RPM/HR/VO2    
Period 3  RPM/HR/VO2    
2  3:10 20 – 30 – 20 – 30 – 15 5:05  
Period 1  RPM/HR/VO2    
Period 2  RPM/HR/VO2    
Period 3  RPM/HR/VO2    
3  6:00 30 – 20 – 10 7:00  
Period 1  RPM/HR/VO2    
Period 2  RPM/HR/VO2    
Period 3  RPM/HR/VO2    
4  10:10 10 – 20 – 40 11:20  
Period 1  RPM/HR/VO2    
Period 2  RPM/HR/VO2    
Period 3  RPM/HR/VO2    
5  12:10 30 – 20 – 20 13:20  
Period 1  RPM/HR/VO2    
Period 2  RPM/HR/VO2    
Period 3  RPM/HR/VO2    
6  15:40 10 – 20 – 10 16:20  
Period 1  RPM/HR/VO2    
Period 2  RPM/HR/VO2    
Period 3  RPM/HR/VO2    
7  17:20 20 – 40– 20 – 40 – 20 – 10– 10 20:00  
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Period 1  RPM/HR/VO2    
Period 2  RPM/HR/VO2    
Period 3  RPM/HR/VO2    
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APPENDIX E: ADDITIONAL TABLES AND GRAPHS  
Table A1. Anthropometric and physical plus physiological fitness profiles of competitive youth ice hockey players with T1D 
 Age 
(yrs) 
Sex Height 
(cm) 
Weight 
(Kg) 
WC 
(cm) 
Skinfolds 
(mm) 
Hockey 
Level 
VO2 max 
(mL·kg-
1·min-1) 
HR min 
(bpm) 
HR max 
(bpm) 
Peak 
Power 
(Watts) 
Peak 
Power 
(Watts/kg) 
Fatigue 
(%) 
T1D 1 13 F 158 53.3 71 53.8 AA 56.2 67 202 471.9 8.9 46.4 
T1D 2 17 M 175 73 79 56.6 Jr. A 49.8 51 192 735.3 10.1 51.7 
T1D 3 14 M 167 58.7 74 57.7 AAA 59 51 190 647.4 11.0 48.0 
T1D 4 17 F 167 64.4 74 95.3 A 51.8 57 209 567.0 8.8 39.3 
T1D 5 13 F 157 64.1 74 102.7 AA 43.3 48 186 460.0 7.2 43.1 
T1D 6 15 M 178 76.6 84 63 A 58.9 54 197 747.4 9.8 39.0 
T1D 7 15 M 176 80.6 86.7 53.2 AAA 59.3 51 188 910.1 11.3 65.0 
T1D 8 13 M 171 67.7 77  AAA 56.9 50 202 786.9 11.6 50.1 
T1D 9 15 M 175 65.1 73.1 35.9 AAA 56 55 204 705.1 10.8 38.6 
Mean 
± SD 
14.7   
± 1.58 
 169.3       
± 7.7 
67.1         
± 8.6 
77.0         
± 5.3 
64.8            
± 22.6 
 54.6 ± 5.3 53.8 ± 
5.7 
196.7 ± 
8.1 
670.1            
± 148.9 
9.9 ± 1.4 46.4 ± 
8.9 
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Table A2. Anthropometric and physical plus physiological fitness profiles of competitive youth ice hockey players without T1D 
 Age 
(yrs) 
Sex Height 
(cm) 
Weight 
(Kg) 
WC 
(cm) 
Skinfolds 
(mm) 
Hockey 
Level 
VO2 max 
(mL·kg-
1·min-1) 
HR min 
(bpm) 
HR max 
(bpm) 
Peak 
Power 
(Watts) 
Peak 
Power 
(Watts/kg) 
Fatigue 
(%) 
ND 1 13 F 163 55.5 74 55.8 AA 52.7 65 204 484.8 8.7 38.1 
ND 2 17 M 174 75.6 83 62.4 AA 62.4 44 194 886.1 11.7 56.3 
ND 3 14 M 170 68.5 77 70.8 AAA 63.3 52 193 770.9 11.3 54.5 
ND 4 17 F 170 57.3 73 49.9 A 54.8 59 201 528.5 9.2 33.8 
ND 5 13 F 154 51.2 72 52.8 AA 46.5 63 189 487.0 9.5 39.0 
ND 6 15 M 167 71.4 83 53.2 AA 52.2 43 201 635.4 8.9 54.5 
ND 7 15 M 184 82.2 89 39.2 AAA 61.1 53 195 1019.0 12.4 54.3 
ND 8 13 M 176 73.1 79  AAA 64.1 50 195 860.5 11.8  
ND 9 15 M 173 61.3 71 33.5 AAA 53 43 203 772.3 12.6 56.7 
Mean 
± SD 
14.7 
±1.58 
 170.1 
±8.5 
66.2 
±10.4 
78.0 
±6.1 
52.2 
±11.9 
 56.7 ±6.2 52.4 
±8.4 
197.2 
±5.2 
716.1 
±192.1 
10.7 ± 1.6 48.4 
±9.6 
ND represents the non-diabetic hockey players with corresponding numbers to their T1D counterpart 
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Figure A1. %VO2max for all study participants combined across all 3 periods of a simulation 
hockey game. No differentiation between T1D and ND groups. 
 
A  
B  
 
The above graphs illustrate the mean VO2 response expressed as a percentage of %VO2max for 
all study participants during each shift and bench interval between the 3 periods. The shaded 
areas represent the shift intervals and the white areas represent the bench intervals. The VO2 
response across the 3 periods is consistent, and during the shifts the participants achieved peak 
VO2 values ranging between 50-80% of VO2max. Panel A. Includes the mean %VO2max along 
with the standard errors for all participants (M ± SE). 
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Figure A2. %HRmax for all study participants with and without T1D across all 3 periods of a 
simulation hockey game. No differentiation between T1D and ND groups.  
 
A  
B  
 
The above graphs illustrate the mean HR response expressed as a percentage of HR for all study 
participants during each shift and bench interval between the 3 periods. The shaded areas 
represent the shift intervals and the white areas represent the bench intervals. The HR 
response across the 3 periods is consistent, and during the shifts the participants achieved peak 
HR values ranging between 80-90% HRmax. Panel A. Includes the mean %HRmax along with the 
standard errors for all participants (M ± SE). 
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Figure A3. The 10-second averaged VO2 (ml·Kg
-1·min-1) response across 3 periods of a 
simulation hockey game comparing individuals with and without T1D 
 
 
 
 
The VO2 response between the T1D and ND group are similar. It seems that the ND individuals 
were able to reach greater VO2 values during the shifts, but these differences were not 
significant. During the shifts the participants’ VO2 ranged between 30-50 ml·Kg
-1·min-1. 
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Figure A4. The 10-second averaged HR (bpm) response across 3 periods of a simulation hockey 
game comparing individuals with and without T1D 
 
 
 
 
The HR response is paralleled between the T1D and ND groups during all 3 periods. During the 
shifts the HR for both groups ranged between 150-190 bpm. 
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Table A3. Comparison of the average nadir and peak oxygen consumption rate expressed 
relative to VO2max, in response to a simulation hockey game between individuals with and 
without T1D (M ± SD). 
  Period 1 Period 2 Period 3 
  T1D (n=7) ND (n=6) T1D (n=7) ND (n=6) T1D (n=7) ND (n=6) 
Rest  0.19 ± 0.08 0.18 ± 0.07 0.30 ± 0.14 0.24 ± 0.12 0.20 ± 0.09 0.18 ± 0.05 
Shift 
1 
High 0.80 ± 0.13 0.85 ± 0.15 0.76 ± 0.15 0.78 ± 0.14 0.78 ± 0.15 0.77 ± 0.14 
Low 0.41 ± 0.15 0.47 ± 0.11 0.40 ± 0.10 0.42 ± 0.09 0.37 ± 0.10 0.38 ± 0.11 
Bench 
1 
High 0.66 ± 0.09 0.62 ± 0.18 0.67 ± 0.07 0.62 ± 0.13 0.60 ± 0.11 0.65 ± 0.13 
Low 0.26 ± 0.09 0.28 ± 0.06 0.27 ± 0.08 0.25 ± 0.08 0.23 ± 0.05 0.23 ± 0.02 
Shift 
2 
High 0.77 ± 0.13 0.83 ± 0.13 0.74 ± 0.17 0.76 ± 0.14 0.80 ± 0.15 0.83 ± 0.11 
Low 0.48 ± 0.12 0.48 ± 0.06 0.48 ± 0.15 0.40 ± 0.11 0.45 ± 0.12 0.51 ± 0.15 
Bench 
2 
High 0.66 ± 0.12 0.72 ± 0.16 0.62 ± 0.12 0.64 ± 0.16 0.63 ± 0.16 0.68 ± 0.16 
Low 0.45 ± 0.07 0.40 ± 0.07 0.38 ± 0.10 0.38 ± 0.09 0.37 ± 0.08 0.41 ± 0.12 
Shift 
3 
High 0.83 ± 0.09 0.87 ± 0.11 0.78 ± 0.18 0.81 ± 0.15 0.82 ± 0.13 0.86 ± 0.08 
Low 0.60 ± 0.09 0.61 ± 0.11 0.47 ± 0.10 0.55 ± 0.11 0.54 ± 0.09 0.59 ± 0.12 
Bench 
3 
High 0.65 ± 0.10 0.66 ± 0.16 0.56 ± 0.13 0.66 ± 0.13 0.64 ± 0.17 0.72 ± 0.13 
Low 0.19 ± 0.06 0.18 ± 0.03 0.17 ± 0.06 0.17 ± 0.05 0.18 ± 0.06 0.17 ± 0.04 
Shift 
4 
High 0.77 ± 0.16 0.89 ± 0.11 0.74 ± 0.18 0.80 ± 0.14 0.79 ± 0.17 0.84 ± 0.12 
Low 0.44 ± 0.12 0.49 ± 0.07 0.36 ± 0.14 0.40 ± 0.14 0.39 ± 0.13 0.40 ± 0.10 
Bench 
4 
High 0.68 ± 0.14 0.69 ± 0.11 0.64 ± 0.15 0.66 ± 0.10 0.65 ± 0.15 0.69 ± 0.16 
Low 0.48 ± 0.11 0.46 ± 0.09 0.41 ± 0.06 0.45 ± 0.06 0.38 ± 0.04 0.46 ± 0.09 
Shift 
5 
High 0.81 ± 0.11 0.84 ± 0.09 0.83 ± 0.12 0.79 ± 0.16 0.81 ± 0.12 0.87 ± 0.08 
Low 0.63 ± 0.10 0.54 ± 0.11 0.55 ± 0.11 0.53 ± 0.14 0.57 ± 0.16 0.60 ± 0.16 
Bench 
5 
High 0.64 ± 0.10 0.66 ± 0.19 0.59 ± 0.13 0.65 ± 0.19 0.64 ± 0.15 0.66 ± 0.14 
Low 0.23 ± 0.06 0.25 ± 0.05 0.20 ± 0.05 0.22 ± 0.05 0.21 ± 0.07 0.21 ± 0.04 
Shift 
6 
High 0.71 ± 0.16 0.67 ± 0.18 0.76 ± 0.14 0.77 ± 0.19 0.74 ± 0.16 0.76 ± 0.14 
Low 0.37 ± 0.15 0.46 ± 0.10 0.50 ± 0.13 0.44 ± 0.08 0.45 ± 0.12 0.49 ± 0.14 
Bench 
6 
High 0.61 ± 0.14 0.58 ± 0.06 0.62 ± 0.12 0.65 ± 0.11 0.65 ± 0.17 0.67 ± 0.17 
Low 0.35 ± 0.11 0.36 ± 0.04 0.37 ± 0.11 0.39 ± 0.06 0.35 ± 0.11 0.38 ± 0.07 
Shift 
7 
High 0.80 ± 0.11 0.84 ± 0.10 0.81 ± 0.14 0.86 ± 0.08 0.85 ± 0.14 0.87 ± 0.12 
Low 0.47 ± 0.09 0.43 ± 0.07 0.46 ± 0.09 0.46 ± 0.09 0.45 ± 0.13 0.47 ± 0.09 
No differences between T1D and ND groups 
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Table A4. Comparison of the average nadir and peak heart rate expressed relative to HRmax, in 
response to a simulation hockey game between individuals with and without T1D (M ± SD). 
  Period 1 Period 2 Period 3 
  T1D (n=7) ND (n=6) T1D (n=7) ND (n=6) T1D (n=7) ND (n=6) 
REST  0.59 ± 0.13 0.52 ± 0.09 0.72 ± 0.08 0.67 ± 0.05 0.64 ± 0.06 0.62 ± 0.04 
Shift 
1 
High 0.87 ± 0.03 0.87 ± 0.07 0.91 ± 0.04 0.90 ± 0.02 0.91 ± 0.05 0.89 ± 0.04 
Low 0.71 ± 0.06 0.69 ± 0.10 0.76 ± 0.08 0.76 ± 0.03 0.75 ± 0.06 0.73 ± 0.04 
Bench 
1 
High 0.86 ± 0.03 0.85 ± 0.08 0.89 ± 0.03 0.90 ± 0.03 0.89 ± 0.03 0.89 ± 0.03 
Low 0.62 ± 0.11 0.63 ± 0.06 0.69 ± 0.07 0.68 ± 0.04 0.64 ± 0.05 0.65 ± 0.05 
Shift 
2 
High 0.86 ± 0.09 0.88 ± 0.02 0.91 ± 0.04 0.89 ± 0.02 0.90 ± 0.03 0.89 ± 0.02 
Low 0.72 ± 0.12 0.76 ± 0.04 0.78 ± 0.08 0.76 ± 0.04 0.78 ± 0.05 0.76 ± 0.05 
Bench 
2 
High 0.90 ± 0.04 0.89 ± 0.01 0.90 ± 0.04 0.89 ± 0.03 0.90 ± 0.05 0.89 ± 0.02 
Low 0.78 ± 0.03 0.79 ± 0.03 0.78 ± 0.05 0.78 ± 0.03 0.75 ± 0.07 0.76 ± 0.06 
Shift 
3 
High 0.92 ± 0.03 0.91 ± 0.01 0.92 ± 0.04 0.91 ± 0.02 0.92 ± 0.04 0.91 ± 0.02 
Low 0.82 ± 0.02 0.83 ± 0.04 0.82 ± 0.06 0.81 ± 0.03 0.81 ± 0.06 0.79 ± 0.04 
Bench 
3 
High 0.90 ± 0.02 0.90 ± 0.01 0.88 ± 0.05 0.90 ± 0.02 0.92 ± 0.04 0.90 ± 0.01 
Low 0.63 ± 0.04 0.63 ± 0.06 0.63 ± 0.06 0.65 ± 0.03 0.64 ± 0.06 0.62 ± 0.03 
Shift 
4 
High 0.93 ± 0.02 0.88 ± 0.12 0.92 ± 0.03 0.92 ± 0.02 0.91 ± 0.03 0.91 ± 0.03 
Low 0.76 ± 0.05 0.71 ± 0.14 0.75 ± 0.08 0.75 ± 0.04 0.77 ± 0.05 0.74 ± 0.03 
Bench 
4 
High 0.92 ± 0.03 0.92 ± 0.02 0.89 ± 0.04 0.91 ± 0.02 0.90 ± 0.05 0.92 ± 0.02 
Low 0.83 ± 0.05 0.84 ± 0.02 0.79 ± 0.05 0.82 ± 0.02 0.76 ± 0.05 0.79 ± 0.06 
Shift 
5 
High 0.93 ± 0.03 0.93 ± 0.02 0.93 ± 0.03 0.92 ± 0.02 0.92 ± 0.05 0.92 ± 0.02 
Low 0.83 ± 0.09 0.85 ± 0.03 0.86 ± 0.05 0.84 ± 0.03 0.82 ± 0.06 0.82 ± 0.05 
Bench 
5 
High 0.92 ± 0.04 0.92 ± 0.04 0.88 ± 0.05 0.90 ± 0.04 0.91 ± 0.04 0.90 ± 0.03 
Low 0.66 ± 0.10 0.68 ± 0.06 0.67 ± 0.05 0.67 ± 0.04 0.65 ± 0.06 0.66 ± 0.04 
Shift 
6 
High 0.87 ± 0.04 0.83 ± 0.06 0.88 ± 0.03 0.87 ± 0.03 0.87 ± 0.05 0.86 ± 0.03 
Low 0.78 ± 0.05 0.77 ± 0.06 0.80 ± 0.05 0.76 ± 0.06 0.80 ± 0.06 0.78 ± 0.03 
Bench 
6 
High 0.87 ± 0.03 0.86 ± 0.05 0.89 ± 0.03 0.88 ± 0.03 0.90 ± 0.05 0.89 ± 0.03 
Low 0.75 ± 0.07 0.75 ± 0.04 0.76 ± 0.05 0.77 ± 0.04 0.74 ± 0.10 0.75 ± 0.04 
Shift 
7 
High 0.93 ± 0.03 0.91 ± 0.04 0.91 ± 0.06 0.92 ± 0.02 0.93 ± 0.04 0.92 ± 0.02 
Low 0.80 ± 0.05 0.79 ± 0.05 0.82 ± 0.04 0.83 ± 0.04 0.81 ± 0.08 0.81 ± 0.04 
No differences between T1D and ND groups 
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Table A5. Comparison of the combined average nadir and peak oxygen consumption rate, 
expressed relative to VO2max, between the 3 periods of a simulation hockey game (M ± SD). 
  COMBINED (n=13) 
  Period 1 Period 2 Period 3 
Rest  0.19 ± 0.07 0.27 ± 0.13 0.19 ± 0.07 
Shift 
1 
High 0.82 ± 0.14 0.77 ± 0.14 0.78 ± 0.14 
Low 0.44 ± 0.13 0.41 ± 0.09‡ 0.37 ± 0.10‡ 
Bench 
1 
High 0.64 ± 0.13 0.65 ± 0.10 0.63 ± 0.12 
Low 0.27 ± 0.07 0.26 ± 0.08 0.23 ± 0.04 
Shift 
2 
High 0.80 ± 0.13 0.75 ± 0.15‡ 0.81 ± 0.13‡ 
Low 0.48 ± 0.09 0.44 ± 0.13 0.48 ± 0.14 
Bench 
2 
High 0.69 ± 0.14 0.63 ± 0.13 0.65 ± 0.16 
Low 0.43 ± 0.07 0.38 ± 0.09 0.39 ± 0.10 
Shift 
3 
High 0.85 ± 0.10 0.79 ± 0.16 0.84 ± 0.11 
Low 0.60 ± 0.09+ 0.51 ± 0.11+‡ 0.56 ± 0.11‡ 
Bench 
3 
High 0.65 ± 0.12 0.61 ± 0.13 0.68 ± 0.15 
Low 0.18 ± 0.04 0.17 ± 0.05 0.18 ± 0.05 
Shift 
4 
High 0.83 ± 0.15 0.77 ± 0.16‡ 0.82 ± 0.15‡ 
Low 0.46 ± 0.10 0.38 ± 0.13 0.40 ± 0.11 
Bench 
4 
High 0.69 ± 0.12 0.65 ± 0.13 0.67 ± 0.15 
Low 0.47 ± 0.10 0.42 ± 0.06 0.42 ± 0.08 
Shift 
5 
High 0.82 ± 0.10 0.81 ± 0.13 0.84 ± 0.11 
Low 0.59 ± 0.11 0.54 ± 0.12 0.58 ± 0.16 
Bench 
5 
High 0.65 ± 0.14 0.62 ± 0.16 0.65 ± 0.14 
Low 0.24 ± 0.21 0.21 ± 0.06 0.05 ± 0.06 
Shift 
6 
High 0.69 ± 0.17 0.76 ± 0.16 0.75 ± 0.14 
Low 0.46 ± 0.12 0.48 ± 0.11 0.47 ± 0.12 
Bench 
6 
High 0.60 ± 0.11 0.63 ± 0.11 0.66 ± 0.16 
Low 0.36 ± 0.08 0.38 ± 0.09 0.36 ± 0.09 
Shift 
7 
High 0.82 ± 0.10 0.83 ± 0.12 0.86 ± 0.13 
Low 0.45 ± 0.08 0.46 ± 0.09 0.46 ± 0.11 
+ p < 0.05 Significant difference between periods 1 and 2 
‡ p < 0.05 Significant difference between periods 2 and 3 
† p < 0.05 Significant difference between periods 1 and 3 
 
Some significant differences were observed in the combined average %VO2max values during 
some of the play shift and bench intervals. During play shift 1, the average %VO2max low was 
significantly higher in period 2 compared with period 3. During play shift 2, the average 
%VO2max high was significantly lower in period 2 compared with period 3. During play shift 3, 
the average %VO2max low was significantly greater in period 1 compared to period 3, period 2 
was significantly lower than period 3, and no significant differences were observed between 
periods 1 and 3. Lastly, during play shift 4 the average %VO2max high was significantly lower in 
period 2 compared with period 3. 
112 
 
Table A6. Comparison of the combined average nadir and peak heart rate, expressed relative to 
HRmax, between the 3 periods of a simulation hockey game (M ± SD). 
  COMBINED (n=13) 
  P1 P2 P3 
REST  0.56 ± 0.11+ 0.70 ± 0.07+‡ 0.63 ± 0.05‡ 
Shift 
1 
High 0.87 ± 0.05+ 0.91 ± 0.03 0.90 ± 0.04 
Low 0.70 ± 0.08 0.76 ± 0.06 0.74 ± 0.05 
Bench 
1 
High 0.85 ± 0.06 0.89 ± 0.03 0.89 ± 0.03 
Low 0.62 ± 0.09 0.69 ± 0.06 0.65 ± 0.05 
Shift 
2 
High 0.87 ± 0.06 0.90 ± 0.03 0.90 ± 0.03 
Low 0.74 ± 0.09 0.77 ± 0.06 0.77 ± 0.05 
Bench 
2 
High 0.89 ± 0.03 0.90 ± 0.04 0.90 ± 0.04 
Low 0.79 ± 0.03 0.78 ± 0.05 0.75 ± 0.06 
Shift 
3 
High 0.92 ± 0.02 0.92 ± 0.03 0.91 ± 0.03 
Low 0.83 ± 0.03 0.82 ± 0.05 0.80 ± 0.05 
Bench 
3 
High 0.90 ± 0.02 0.89 ± 0.04 0.91 ± 0.03 
Low 0.63 ± 0.05 0.64 ± 0.05‡ 0.63 ± 0.05‡ 
Shift 
4 
High 0.91 ± 0.09 0.92 ± 0.03 0.91 ± 0.03 
Low 0.74 ± 0.10 0.75 ± 0.06 0.76 ± 0.04 
Bench 
4 
High 0.92 ± 0.02 0.90 ± 0.03 0.90 ± 0.04 
Low 0.83 ± 0.04† 0.81 ± 0.04 0.78 ± 0.05† 
Shift 
5 
High 0.93 ± 0.03 0.93 ± 0.03 0.92 ± 0.04 
Low 0.84 ± 0.07 0.85 ± 0.04 0.82 ± 0.05 
Bench 
5 
High 0.92 ± 0.04 0.89 ± 0.04 0.91 ± 0.03 
Low 0.67 ± 0.08 0.67 ± 0.04 0.65 ± 0.05 
Shift 
6 
High 0.85 ± 0.05 0.87 ± 0.03 0.87 ± 0.04 
Low 0.78 ± 0.05 0.78 ± 0.06 0.79 ± 0.05 
Bench 
6 
High 0.86 ± 0.04 0.88 ± 0.03 0.90 ± 0.04 
Low 0.75 ± 0.06 0.77 ± 0.04 0.75 ± 0.07 
Shift 
7 
High 0.92 ± 0.03 0.91 ± 0.05 0.93 ± 0.03 
Low 0.80 ± 0.05 0.83 ± 0.04 0.81 ± 0.06 
+ p < 0.05 Significant difference between periods 1 and 2 
‡ p < 0.05 Significant difference between periods 2 and 3 
† p < 0.05 Significant difference between periods 1 and 3 
 
Some significant differences were observed in the combined average %HRmax values during 
some of the play shift and bench intervals. At rest, %HRmax was significantly lower in period 1 
compared to period 2, period 2 was significantly greater than period 3, and no differences were 
observed between period 1 and period 3. During play shift 1, the average %HRmax low was 
significantly lower in period 1 than period 2. During bench 3, the average %HRmax low was 
significantly greater in period 2 then period 3. Lastly, during bench 4 the average %HRmax low 
was significantly greater in period 1 compared with period 3. 
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Figure A5. The average nadir and peak %VO2max and %HRmax for all study participants during 
the 3 period of a simulation hockey game (M ± SE). 
A C  
B  D  
+ p < 0.05 Significant difference between periods 1 and 2 
‡ p < 0.05 Significant difference between periods 2 and 3 
† p < 0.05 Significant difference between periods 1 and 3 
 
 
Some significant differences were observed during some of the play shift and bench intervals.  
Panel A. Shows the differences in the average nadir %VO2max values for all play shift and bench 
intervals between periods.  Panel B. Shows the differences in the average peak %VO2max values 
for all play shift and bench intervals between periods. Panel C. Shows the differences in the 
average nadir %HRmax values for all play shift and bench intervals between periods. Panel D. 
Shows the differences in the average peak %HRmax values for all play shift and bench intervals 
between periods. 
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Table A7. Results of the average nadir and peak %VO2max and %HRmax data analysis for all 
study participants: Two-way repeated measures ANOVA 
%VO2max Highs Type lll Sum of 
Squares 
df Mean Square F Sig. 
Rest      
Period 579.214 2 289.607 4.247 .028 
Period*Diabetes 31.747 2 15.873 .233 .794 
Error(Period) 1500.100 22 68.186   
Diabetes 
Between-Subject 
Effect 
102.525 1 102.525 .753 .404 
S1      
Period 217.336 1.072 202.725 .870 .377 
Period*Diabetes 50.158 1.072 46.786 .201 .679 
Error(Period) 2746.719 11.793 232.14   
Diabetes 
Between-Subject 
Effect 
37.306 1 37.306 .103 .754 
B1      
Period 20.782 2 10.393 .266 .769 
Period*Diabetes 177.716 2 88.858 2.278 .126 
Error(Period) 858.337 22 39.015   
Diabetes 
Between-Subject 
Effect 
17.540 11 17.540 .047 .833 
S2      
Period 278.616 2 139.308 3.475 .049 
Period*Diabetes 45.804 2 22.902 .571 .573 
Error(Period) 882.056 22 40.093   
Diabetes 
Between-Subject 
Effect 
111.260 1 111.260 .218 .650 
B2      
Period 243.013 2 121.506 3.217 .059 
Period*Diabetes 43.808 2 21.904 .580 .568 
Error(Period) 830.987 22 37.772   
Diabetes 
Between-Subject 
Effect 
178.550 1 178.550 .312 .588 
S3      
Period 250.528 2 125.264 1.987 .161 
Period*Diabetes 3.679 2 1.839 .029 .971 
Error(Period) 1386.681 22 63.031   
Diabetes 
Between-Subject 
132.005 1 132.005 .321 .555 
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Effect 
B3      
Period 346.140 2 173.070 3.549 .046 
Period*Diabetes 131.203 2 65.601 1.345 .281 
Error(Period) 1072.744 22 48.761   
Diabetes 
Between-Subject 
Effect 
374.387 1 374.387 .810 .387 
S4      
Period 264.138 1.239 213.154 2.211 .158 
Period*Diabetes 65.490 2 32.745 .548 .508 
Error(Period) 1314.296 13.631 96.419   
Diabetes 
Between-Subject 
Effect 
581.906 1 581.906 1.062 .325 
B4      
Period 85.915 2 42.958 1.359 .278 
Period*Diabetes 5.719 2 2.859 .090 .914 
Error(Period) 695.641 22 31.620   
Diabetes 
Between-Subject 
Effect 
55.939 1 55.939 .109 .747 
S5      
Period 69.634 2 34.817 .684 .515 
Period*Diabetes 152.480 2 76.240 1.498 .245 
Error(Period) 1119.463 22 50.885   
Diabetes 
Between-Subject 
Effect 
25.158 1 25.158 .086 .775 
B5      
Period 73.890 2 36.945 .471 .630 
Period*Diabetes 25.230 2 12.615 .161 .852 
Error(Period) 1725.470 22 78.431   
Diabetes 
Between-Subject 
Effect 
126.167 1 126.167 .245 .630 
S6      
Period 389.281 2 194.640 1.961 .165 
Period*Diabetes 59.908 2 29.954 .302 .742 
Error(Period) 2183.545 22 99.252   
Diabetes 
Between-Subject 
Effect 
.782 1 .782 .001 .971 
B6      
Period 291.690 2 145.845 2.237 .131 
Period*Diabetes 69.108 2 34.554 .530 .596 
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Error(Period) 1434.437 22 65.202   
Diabetes 
Between-Subject 
Effect 
7.240 1 7.240 .018 .896 
S7      
Period 100.619 2 50.309 1.017 .378 
Period*Diabetes 17.243 2 8.622 .174 .841 
Error(Period) 1088.730 22 49.488   
Diabetes 
Between-Subject 
Effect 
146.521 1 146.521 .459 .512 
 
%VO2max Lows Type lll Sum of 
Squares 
df Mean Square F Sig. 
S1      
Period 265.294 1.219 132.647 3.308 .085 
Period*Diabetes 30.11 1.219 24.626 .374 .692 
Error(Period) 882.166 13.405 65.808   
Diabetes 
Between-Subject 
Effect 
87.185 1 87.185 .299 .596 
B1      
Period 112.733 2 56.366 2.595 .097 
Period*Diabetes 14.961 2 7.480 .344 .712 
Error(Period) 477.952 22 21.725   
Diabetes 
Between-Subject 
Effect 
.115 1 .115 .001 .973 
S2      
Period 132.388 2 66.194 1.115 .346 
Period*Diabetes 267.557 2 133.778 2.253 .129 
Error(Period) 1306.218 22 59.374   
Diabetes 
Between-Subject 
Effect 
2.940 1 2.940 .009 .927 
B2      
Period 156.986 2 78.493 2.755 .086 
Period*Diabetes 161.833 2 80.916 2.840 .080 
Error(Period) 626.830 22 28.492   
Diabetes 
Between-Subject 
Effect 
1.908 1 1.908 .011 .919 
S3      
Period 5757.152 1.350 287.576 14.076 .001 
Period*Diabetes 77.732 1.350 57.570 1.902 .189 
Error(Period) 449.475 14.852 30.263   
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Diabetes 
Between-Subject 
Effect 
186.157 1 186.157 .675 .429 
B3      
Period 14.550 1.169 12.448 .557 .496 
Period*Diabetes 5.709 1.169 4.884 .218 .686 
Error(Period) 287.526 12.858 22.362   
Diabetes 
Between-Subject 
Effect 
1.670 11 52.332 .032 .861 
S4      
Period 497.907 2 248.954 3.783 .039 
Period*Diabetes 33.846 2 16.923 .257 .776 
Error(Period) 1447.883 22 65.813   
Diabetes 
Between-Subject 
Effect 
111.521 1 111.521 .377 .552 
B4      
Period 160.548 2 80.274 3.794 .038 
Period*Diabetes 158.564 2 79.282 3.747 .040 
Error(Period) 465.536 22 21.161   
Diabetes 
Between-Subject 
Effect 
112.095 1 112.095 .770 .399 
S5      
Period 154.798 2 77.399 1.534 .238 
Period*Diabetes 215.386 2 107.693 2.134 .142 
Error(Period) 1110.168 22 50.462   
Diabetes 
Between-Subject 
Effect 
58.027 1 58.027 .138 .717 
B5      
Period 84.662 2 42.332 2.767 .085 
Period*Diabetes 14.561 2 7.280 .476 .628 
Error(Period) 336.599 22 15.300   
Diabetes 
Between-Subject 
Effect 
11.694 1 11.694 .194 .668 
S6      
Period 4.573 2 2.286 .034 .966 
Period*Diabetes 185.611 2 92.805 1.394 269 
Error(Period) 1464.463 22 66.566   
Diabetes 
Between-Subject 
Effect 
3.398 1 3.398 .011 .919 
B6      
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Period 27.337 2 13.668 .357 .704 
Period*Diabetes 5.831 2 2.916 .076 .927 
Error(Period) 842.054 22 38.275   
Diabetes 
Between-Subject 
Effect 
41.365 1 41.365 .254 .624 
S7      
Period 4.780 2 2.390 .103 .903 
Period*Diabetes 55.712 2 27.856 1.198 .321 
Error(Period) 511.608 22 23.255   
Diabetes 
Between-Subject 
Effect 
3.927 1 3.927 .016 .901 
 
%HRmax Highs Type lll Sum of 
Squares 
df Mean Square F Sig. 
Rest      
Period 1278.130 1.308 976.903 16.221 .001 
Period*Diabetes 44.899 1.308 34.318 .570 .507 
Error(Period) 866.723 14.392 60.223   
Diabetes 
Between-Subject 
Effect 
165.842 1 165.842 1.316 .276 
S1      
Period 88.943 2 44.471 5.023 .016 
Period*Diabetes 13.660 2 6.830 .771 .474 
Error(Period) 194.776 22 8.853   
Diabetes 
Between-Subject 
Effect 
8.314 1 8.314 .244 .631 
B1      
Period 138.718 1.286 107.851 5.362 .029 
Period*Diabetes 3.954 1.286 3.074 .153 .764 
Error(Period) 284.586 14.148 20.115   
Diabetes 
Between-Subject 
Effect 
.331 1 .331 .011 .918 
S2      
Period 78.558 1.080 72.757 2.674 .127 
Period*Diabetes 32.302 1.080 29.917 1.099 .321 
Error(Period) 323.195 11.877 27.212   
Diabetes 
Between-Subject 
Effect 
.242 1 .242 .008 .930 
B2      
Period 1.520 2 .760 .121 .886 
119 
 
Period*Diabetes .940 2 .470 .075 .928 
Error(Period) 137.922 22 6.269   
Diabetes 
Between-Subject 
Effect 
10.913 1 10.913 .456 .514 
S3      
Period 2.836 2 1.418 .429 .656 
Period*Diabetes .704 2 .352 .107 .899 
Error(Period) 72.659 22 3.303   
Diabetes 
Between-Subject 
Effect 
9.478 1 9.478 .546 .514 
B3      
Period 15.791 2 7.895 1.384 .272 
Period*Diabetes 26.444 22 13.222 2.318 .122 
Error(Period) 125.492 2 5.704   
Diabetes 
Between-Subject 
Effect 
.669 1 .669 .045 .836 
S4      
Period 17.873 1.055 16.943 .323 .592 
Period*Diabetes 63.027 1.055 59.749 1.140 .311 
Error(Period) 608.256 11.604 52.420   
Diabetes 
Between-Subject 
Effect 
45.500 1 45.500 1.313 .276 
B4      
Period 27.250 1.349 20.198 1.416 .264 
Period*Diabetes 16.955 1.349 12.567 .881 .395 
Error(Period) 211.707 14.841 14.265   
Diabetes 
Between-Subject 
Effect 
17.727 1 17.727 1.565 .237 
S5      
Period 6.981 2 3.491 1.066 .361 
Period*Diabetes 3.576 2 1.788 .546 .587 
Error(Period) 72.026 22 3.274   
Diabetes 
Between-Subject 
Effect 
9.221 1 9.221 .387 .546 
B5      
Period 40.675 2 20.337 1.489 .248 
Period*Diabetes 13.856 2 6.928 .507 .609 
Error(Period) 300.525 22 13.660   
Diabetes 
Between-Subject 
2.442E-005 1 2.442E-005 .000 .999 
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Effect 
S6      
Period 36.018 2 18.009 2.413 .113 
Period*Diabetes 13.919 22 6.960 .932 .409 
Error(Period) 164.197 2 7.464   
Diabetes 
Between-Subject 
Effect 
35.783 1 35.783 1.047 .328 
B6      
Period 71.756 2 35.878 3.369 .053 
Period*Diabetes .925 2 .463 .043 .958 
Error(Period) 234.276 22 10.649   
Diabetes 
Between-Subject 
Effect 
9.146 1 9.146 .420 .530 
S7      
Period 15.860 2 7.930 .857 .438 
Period*Diabetes 10.822 2 5.411 .585 .566 
Error(Period) 203.535 22 9.252   
Diabetes 
Between-Subject 
Effect 
10.621 1 10.621 .440 .521 
 
%HRmax Lows Type lll Sum of 
Squares 
df Mean Square F Sig. 
S1      
Period 247.048 2 123.524 4.614 .021 
Period*Diabetes 7.296 2 3.648 .136 .873 
Error(Period) 588.995 22 26.772   
Diabetes 
Between-Subject 
Effect 
14.441 1 14.441 .180 .679 
B1      
Period 266.600 1.325 201.202 5.218 .030 
Period*Diabetes 5.547 1.325 4.186 .109 .815 
Error(Period) 562.024 14.575 38.560   
Diabetes 
Between-Subject 
Effect 
.744 1 .744 .008 .930 
S2      
Period 78.526 1.126 69.765 .983 .352 
Period*Diabetes 66.645 1.126 59.210 .834 .392 
Error(Period) 879.000 12.381 70.994   
Diabetes 
Between-Subject 
Effect 
1.395 1 1.395 .021 .887 
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B2      
Period 69.418 2 34.709 2.968 .072 
Period*Diabetes .460 2 .230 .020 .981 
Error(Period) 257.284 20.498 12.552   
Diabetes 
Between-Subject 
Effect 
2.773 1 2.773 .048 .831 
S3      
Period 49.126 2 24.563 3.080 .066 
Period*Diabetes 11.012 2 5.506 .690 .512 
Error(Period) 175.432 22 7.974   
Diabetes 
Between-Subject 
Effect 
1.011 1 1.011 .024 .879 
B3      
Period 14.839 1.051 14.126 .564 .476 
Period*Diabetes 14.675 1.051 13.970 .558 .478 
Error(Period) 289.387 11.556 25.043   
Diabetes 
Between-Subject 
Effect 
.000 1 .000 .000 .994 
S4      
Period 29.645 2 14.823 .395 .678 
Period*Diabetes 36.401 2 18.201 .485 .622 
Error(Period) 825.559 22 37.525   
Diabetes 
Between-Subject 
Effect 
73.256 1 73.256 .905 .362 
B4      
Period 207.945 2 103.973 9.847 .001 
Period*Diabetes 13.806 2 6.903 .654 .530 
Error(Period) 232.297 22 10.559   
Diabetes 
Between-Subject 
Effect 
48.206 1 48.206 1.335 .272 
S5      
Period 45.477 1.344 33.827 1.096 .334 
Period*Diabetes 27.132 1.344 20.181 .654 .476 
Error(Period) 456.507 14.788 30.869   
Diabetes 
Between-Subject 
Effect 
.162 1 .162 .003 .957 
B5      
Period 24.297 2 12.148 .491 .619 
Period*Diabetes 12.120 2 6.060 .245 .785 
Error(Period) 544.809 22 24.764   
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Diabetes 
Between-Subject 
Effect 
7.740 1 7.740 .126 .729 
S6      
Period 6.949 2 3.475 .274 .763 
Period*Diabetes 17.936 2 8.969 .707 .504 
Error(Period) 279.188 22 12.690   
Diabetes 
Between-Subject 
Effect 
77.590 1 77.590 1.432 .257 
B6      
Period 46.074 2 23.037 .702 .506 
Period*Diabetes 2.160 2 1.080 .033 .968 
Error(Period) 722.244 22 32.829   
Diabetes 
Between-Subject 
Effect 
2.684 1 2.684 .060 .811 
S7  2    
Period 53.277 2 1.212 1.212 .317 
Period*Diabetes 9.902 22 .225 .225 .800 
Error(Period) 483.353 1 .010   
Diabetes 
Between-Subject 
Effect 
.372   .010 .920 
 
